human
lung
expos
daili
liter
inspir
ambient
air
continu
aspir
small
amount
nasopharyng
secret
sleep
kikuchi
et
al
depend
qualiti
air
environ
resid
flora
nasopharynx
respiratori
tree
face
enorm
task
oxygen
blood
across
moist
thin
alveolarcapillari
wall
approxim
pm
yet
resist
infect
mechan
mechan
innat
host
defens
import
prevent
infect
acquir
immun
essenti
prevent
recurr
chronic
infect
made
strikingli
evid
increas
number
sever
pulmonari
infect
immunocompromis
host
newhous
et
al
mason
nelson
lung
true
epitheli
surfac
interfac
environ
develop
sever
strategi
avoid
infect
import
compon
ofthes
strategi
host
must
abl
downregul
nonspecif
immunemedi
inflamm
failur
regul
local
immun
result
diseas
asthma
hypersensit
pneumon
perhap
sarcoidosi
idiopath
interstiti
pneumon
holt
djukanov
et
al
oconnor
fitzgerald
thu
desir
enhanc
protect
pulmonari
immun
respons
vaccin
prevent
control
unwant
respons
underli
need
studi
basic
immun
mechan
lung
furthermor
understand
critic
immunoregulatori
mechan
may
lead
strategi
prevent
control
lung
transplant
reject
immunemedi
lung
damag
bone
marrow
transplant
patient
number
recent
review
discuss
import
issu
develop
pulmonari
immun
respons
agostini
et
al
hanc
lipscomb
et
al
gyetko
toew
holt
bice
goal
chapter
describ
cell
structur
lung
particip
pulmonari
immun
summar
studi
help
explain
lung
respond
challeng
foreign
antigen
particular
emphasi
anim
model
develop
explor
issu
featur
immun
apparatu
uniqu
lung
highlight
import
question
current
investig
indic
import
challeng
understand
host
protect
infect
yet
regul
immun
prevent
tissu
damag
tissu
cultur
power
tool
understand
immunolog
relev
cell
interact
studi
variou
extracellular
signal
influenc
gene
express
cultur
cell
given
import
insight
milieu
could
influenc
cell
behavior
variou
anatom
site
howev
yet
possibl
know
influenc
within
tissu
hypothes
gener
cell
cultur
must
test
uiuo
exampl
alveolar
macrophag
exist
attach
epitheli
cell
migrat
within
layer
surfact
rather
attach
plastic
layer
medium
recent
review
seri
discuss
import
place
lymphocyt
spatial
context
within
host
properli
understand
function
kroemer
et
al
consider
especi
import
lung
consid
develop
pulmonari
immun
spatial
context
use
divid
evolut
immun
respons
lung
three
distinct
overlap
phase
see
fig
lipscomb
affer
phase
antigen
reach
lung
fig
model
affer
central
process
effer
phase
pulmonari
immun
respons
affer
phase
aff
antigen
reach
bronchoalveolar
space
directli
enter
lymphat
l
process
intraepitheli
interstiti
dendrit
cell
dc
enter
lymphat
migrat
lungassoci
lymph
node
laln
central
process
phase
cp
antigen
lung
dc
perhap
antigen
process
resid
lymph
node
dc
present
antigen
lymphocyt
initi
expans
cell
clone
turn
may
help
b
cell
expand
b
cell
immunoglobulin
receptor
recogn
nativ
antigen
determin
effer
phase
eff
recent
activ
cell
b
cell
shown
leav
laln
circul
subsequ
recruit
lung
site
inflamm
exposur
cell
relev
antigen
result
releas
cytokin
amplifi
inflammatori
respons
recruit
nonspecif
effector
cell
monocyt
site
activ
kill
andor
growthinhibit
microorgan
take
antigenpres
cell
apc
present
naiv
cell
express
relev
cell
receptor
tcr
central
process
phase
specif
lymphocyt
clone
expand
differenti
effector
phase
effector
cell
b
lymphoblast
find
way
pulmonari
site
requir
express
specif
immun
respons
phase
event
must
tightli
regul
allow
effect
immun
respons
yet
avoid
excess
potenti
destruct
inflamm
locat
respiratori
tract
phase
occur
somewhat
controversi
bulk
evid
indic
normal
host
reach
lung
antigen
carri
apc
phagocyt
free
lymphat
fluid
drain
lungassoci
lymph
node
laln
lauweryn
baert
lehnert
central
process
occur
effector
cell
releas
effer
lymph
reach
blood
stream
recruit
vasculatur
lung
berman
et
al
mani
investig
consid
lung
broader
context
mucos
immun
conceptu
framework
use
respiratori
tract
sever
distinct
featur
requir
initi
express
lung
immun
consid
separ
immun
respons
mucos
site
respiratori
tract
share
featur
organ
ie
skin
gut
urogenit
tract
epitheli
layer
interact
environ
intern
organ
concept
common
mucos
system
develop
base
evid
immun
lymphocyt
gener
one
surfac
migrat
homolog
distant
mucos
site
mcdermott
bienenstock
mcghee
et
al
return
concept
shortli
addit
concept
lung
must
understood
immunolog
point
view
upper
lower
respiratori
tract
system
exist
kaltreid
kazmierowski
et
al
system
exhibit
distinct
well
common
immun
mechan
upper
respiratori
tract
start
nare
extend
level
termin
bronchiol
pseudo
stratifi
singl
layer
columnar
epithelium
cover
vascular
connect
tissu
lamina
propria
depend
level
airway
also
contain
variabl
number
mucou
gland
smooth
muscl
larger
airway
bound
cartilag
contrast
lower
respiratori
tract
definit
includ
alveolar
duct
alveoli
epithelium
markedli
attenu
frequent
separ
pulmonari
capillari
endothelium
fuse
basement
membran
mechan
antigen
handl
type
locat
number
immunolog
relev
cell
differ
even
within
area
upper
respiratori
tract
strikingli
differ
upper
versu
lower
respiratori
tract
exampl
mucociliari
clearanc
major
mechan
clearanc
particul
upper
tract
contrast
phagocytosi
resid
subsequ
attain
level
upper
tract
remov
mucociliari
elev
character
particul
clearanc
lower
tract
lauweryn
baert
lehnert
anoth
distinct
featur
upper
versu
lower
tract
relat
organ
lymphoid
tissu
upper
tract
lymphocyt
resid
aggreg
diffus
distribut
along
mucosa
upper
tract
anim
speci
may
infiltr
epithelium
bienenstock
et
al
b
sminia
et
al
lower
tract
lymphocyt
present
variabl
number
within
alveoli
interstitium
normal
host
organ
aggreg
occur
sminia
et
al
pabst
import
featur
upper
versu
lower
tract
involv
rel
import
iga
protect
antibodi
thu
igasecret
b
cell
occur
mucosa
upper
tract
iga
major
immunoglobulin
secret
upper
respiratori
tract
although
iga
present
lower
tract
igg
igm
predomin
bronchoalveolar
lavag
bal
fluid
kaltreid
develop
immun
lung
elsewher
requir
relev
cell
display
appropri
surfac
molecul
contact
secret
appropri
factor
ligandreceptor
interact
specif
other
particular
pattern
surfac
molecul
secret
factor
express
interact
immun
cell
determin
type
immun
respons
develop
central
process
furthermor
site
pulmonari
inflamm
pattern
adhes
molecul
cytokinechemokin
express
immun
parenchym
cell
direct
tempo
magnitud
accumul
recruit
cell
mani
recent
studi
emphas
critic
import
cytokin
chemokin
express
adhes
molecul
regul
pulmonari
inflamm
immun
kunkel
et
al
steinstreilein
phipp
redington
et
al
standiford
et
al
jordana
et
al
lukac
et
al
cell
major
initi
regul
immun
lung
includ
macrophag
dendrit
cell
dc
lymphocyt
express
surfac
molecul
secretori
product
depend
perturb
environ
howev
cell
milieu
eg
epitheli
cell
fibroblast
mast
cell
variou
recruit
blood
leukocyt
also
play
import
regulatori
role
briefli
examin
subsequ
section
first
howev
special
featur
lung
macrophag
dc
lymphocyt
discuss
origin
propos
import
apc
lung
lipscomb
divers
group
cell
best
understood
context
lung
immun
phagocyt
regul
immun
nonspecif
inflamm
holt
lipscomb
et
al
inde
bulk
evid
indic
lung
macrophag
unlik
apc
initi
ofprimari
immun
respons
cell
resid
within
airway
level
respiratori
tract
lamina
propria
interstitium
alveolar
region
pleura
within
pleural
space
rumin
speci
lung
macrophag
found
within
pulmonari
capillari
lehnert
brain
lung
macrophag
origin
bone
marrow
van
oud
albla
et
al
springmey
et
al
godleski
brain
mainten
least
resid
popul
partli
deriv
selfrepl
pool
pinkett
et
al
bowden
adamson
sorokin
et
al
tarl
et
al
shellito
et
al
pulmonari
macrophag
phenotyp
function
divers
even
within
singl
compart
readi
access
bronchoalveolar
macrophag
use
bal
divers
cell
frequent
studi
macrophag
obtain
lavag
includ
resid
well
macrophag
resid
within
lumen
bronchi
bronchiol
intralumin
macrophag
distinct
two
cell
popul
readili
made
howev
vast
major
cell
obtain
human
lavag
alveoli
sinc
techniqu
perform
wedg
flexibl
fiberopt
bronchoscop
larg
alveolar
surfac
area
rel
bronchial
surfac
area
sampl
reynold
american
thorac
societi
small
rodent
eg
mice
rat
cathet
typic
place
trachea
larger
proport
recov
cell
bronchi
bronchiol
major
cell
still
alveoli
procedur
perform
correctli
function
attribut
subpopul
resid
studi
studi
exploit
differ
densiti
murphi
herscowitz
shellito
kaltreid
oghiso
predominantli
function
cell
size
anoth
fraction
techniqu
depend
differ
cell
capac
readili
lavag
function
adher
epithelium
andor
resid
bronchial
lumen
versu
alveoli
within
subpopul
differ
express
class
major
histocompat
antigen
mhc
fc
complement
receptor
phagocyt
capac
respons
chemotact
stimuli
cytotox
cytokin
product
capac
suppress
vitro
immun
respons
murphi
herscowitz
shellito
et
al
shellito
kaltreid
oghiso
furthermor
size
function
phenotyp
shift
inflammatori
respons
van
oud
albla
et
al
although
altern
explan
chang
offer
like
one
recent
arriv
peripher
blood
similar
size
phenotyp
circul
monocyt
precursor
thu
studi
subpopul
inde
studi
lung
immun
becom
dictum
investig
must
care
avoid
low
level
chronic
inflamm
hous
experiment
anim
specif
pathogenfre
environ
respiratori
infect
common
nearli
anim
speci
markedli
affect
experiment
result
consider
overst
interstiti
macrophag
im
compar
also
exhibit
size
function
phenotyp
differ
differ
may
reflect
stage
differenti
blood
precursor
like
reflect
environ
physiolog
role
phagocyt
two
distinct
locat
import
membran
molecul
determin
function
macrophag
includ
complement
fc
mannos
scaveng
receptor
well
class
mhc
adhes
signal
molecul
import
differ
mani
exist
depend
locat
lung
macrophag
exampl
mice
im
express
receptor
wherea
resid
van
oud
albla
van
furth
studi
exist
role
interstiti
pleural
intravascular
lung
macrophag
immun
respons
howev
numer
studi
examin
role
stimul
mitogen
alloantigen
antigen
stimul
respons
vitro
surprisingli
studi
often
reach
conflict
conclus
result
differ
anim
speci
use
level
superimpos
suppress
activ
assay
procedur
use
holt
lipscomb
studi
support
concept
poor
apc
prime
cell
even
express
high
level
class
mhc
human
holt
ansfield
et
al
toew
et
al
lipscomb
et
al
bronchoalveolar
cell
contain
fail
act
effect
apc
vitro
either
activ
suppress
fail
express
poorli
understood
accessori
function
may
manifest
poor
lymphocyteaccessori
cell
bind
shellito
et
al
lyon
et
al
kradin
et
al
current
evid
indic
dc
effici
apc
stimul
naiv
cell
especi
cell
although
class
mhcposit
cell
mani
cell
type
capabl
stimul
recent
prime
cell
steinman
croft
variabl
contamin
cell
lung
dc
pollard
lipscomb
presenc
recent
activ
cell
respond
popul
may
well
explain
report
function
effect
apc
rich
et
al
mechan
util
popul
bal
cell
suppress
immun
respons
like
depend
variabl
assay
system
particularli
depend
anim
speci
dog
pgez
product
demenkoff
et
synergist
activ
pgez
oxygen
radic
kaltreid
et
al
shown
import
human
amlymphocyt
contact
lead
inhibit
receptorinduc
intracellular
calcium
increas
respond
cell
describ
yarbrough
et
al
resid
murin
macrophag
particularli
high
number
rel
number
stimul
lung
dc
suppress
mix
lymphocyt
reaction
mlr
secret
tgfp
lipscomb
et
al
furthermor
nitric
oxid
made
murin
may
inhibit
develop
potent
apc
cell
function
lung
dc
evid
suppress
play
role
vivo
indirectli
shown
deplet
intratrach
dose
liposom
contain
macrophag
cytotox
drug
dichloromethylenediphosphon
follow
immun
via
respiratori
tract
anim
demonstr
increas
number
antibodyform
cell
afc
laln
compar
immun
control
pretreat
liposom
thepen
et
al
igg
iga
ige
afc
increas
amsuppress
activ
import
prevent
develop
ofhypersensit
reaction
circumst
lungimmun
import
protect
amsuppress
activ
could
counterproduct
howev
suppress
activ
murin
macrophag
inhibit
exposur
gmcsf
lesser
extent
select
cytokin
bilyk
holt
major
role
am
seem
phagocytos
remov
potenti
danger
particul
solubl
antigen
alveoli
inhibit
local
lung
immun
respons
howev
immun
may
develop
presenc
otherwis
suppress
am
recruit
leukocyt
alveolu
oppos
activ
strong
environment
influenc
result
cytokin
secret
diminish
suppressor
function
immunologist
long
recogn
adher
cell
requir
optim
vitro
immun
respons
whether
one
measur
cell
lymphoprolif
respons
cell
cytokin
product
tdepend
b
cell
respons
also
develop
increas
appreci
role
dc
prime
naiv
cell
sinc
first
identifi
spleen
steinman
cohn
sinc
role
dc
immun
respons
initi
epitheli
surfac
clarifi
littl
doubt
exist
dc
play
pivot
role
initi
immun
respons
skin
review
steinman
furthermor
substanti
support
develop
concept
intraepitheli
dc
function
differ
migrat
region
lymph
node
thu
freshli
isol
langerhan
cell
capabl
process
antigen
stimul
cell
clone
requir
matur
vitro
fulli
effect
stimul
naiv
cell
mlr
time
markedli
reduc
capac
process
antigen
romani
et
al
data
indic
lung
dc
share
number
characterist
skin
dc
like
also
play
critic
role
initi
lung
immun
holt
apc
must
process
antigen
express
context
class
mhc
also
express
appropri
accessori
molecul
enhanc
interact
apc
cell
recent
studi
emphas
import
interact
apc
cell
surfac
andor
express
respond
cell
deliv
second
signal
review
june
et
al
failur
trigger
second
signal
may
caus
cell
interact
apc
via
tcrpeptidemhc
interfac
becom
anerg
hard
et
al
boussioti
et
al
chen
nabavi
produc
state
toler
oivo
van
et
al
receptor
famili
least
two
molecul
immunoglobulin
supergen
famili
express
constituit
dc
contrast
macrophag
b
cell
must
activ
express
molecul
vandenbergh
et
al
import
accessori
molecul
usual
identifi
phenotyp
standard
immunocytochemistri
function
abil
specif
antibodi
block
immun
function
includ
icaml
steinman
present
mani
lung
dc
data
incomplet
express
famili
high
level
constitut
class
mhc
dendrit
shape
dc
exploit
examin
locat
tissu
section
lung
number
investig
dc
form
interdigit
network
airway
epithelium
speci
investig
sertl
et
al
holt
similar
network
describ
skin
langerhan
cell
intraepitheli
dc
particularli
dens
trachea
gradual
diminish
concentr
airway
branch
increas
site
chronic
inflamm
dc
also
exist
connect
tissu
surround
bronchi
bronchiol
perivascular
connect
tissu
alveolar
septa
pleura
small
number
alveolar
space
sertl
et
al
holt
schonhegrad
kradin
et
al
havenith
et
al
van
haarst
et
al
rat
intraperiton
inject
ifni
increas
number
intraepitheli
dc
without
increas
accessori
cell
function
inocul
bacillu
calmetteguerin
bcg
increas
number
dc
could
lavag
alveolu
havenith
et
thu
number
lung
dc
variou
anatom
site
depend
signal
deliv
coincid
inflamm
lung
dc
isol
variabl
degre
success
util
adher
densiti
class
mhc
express
properti
function
phenotyp
featur
studi
lung
macrophag
difficult
cell
separ
dc
singl
cell
suspens
lung
cell
effect
procedur
isol
fairli
pure
dc
popul
requir
exploit
phagocyt
autofluoresc
properti
lung
macrophag
nicod
et
al
pollard
lipscomb
havenith
et
al
use
techniqu
function
dcenrich
lung
cell
assess
function
assay
includ
stimul
periodatetr
lymphocyt
mlr
antigeninduc
stimul
either
memori
cell
lymphoblast
shown
lung
dc
function
well
better
dc
sourc
rochest
et
al
pollard
lipscomb
dc
isol
whole
lung
prepar
phenotyp
heterogen
cell
marker
differ
somewhat
among
anim
speci
even
within
individu
speci
exampl
latter
variat
relat
cdla
express
human
langerhan
cell
skin
various
describ
present
less
sertl
et
al
nicod
et
al
van
haarst
et
al
lung
dc
man
antigen
may
import
stimul
cell
potenti
import
interact
host
defens
lung
view
observ
cell
may
recogn
heatshock
protein
mycobacterium
tuberculosi
mtb
born
et
al
kaufmann
kabelitz
variat
express
cytoplasm
surfac
marker
also
occur
within
popul
lung
dc
exampl
mous
interdigit
cell
antigen
present
half
lung
dc
major
lung
dc
express
heatstabl
antigen
defin
pollard
lipscomb
latter
two
marker
also
uniformli
express
murin
thymu
skin
dc
absent
major
splenic
dc
indic
likelihood
closer
relationship
lung
dc
tissu
dc
rather
dc
primarili
home
bone
marrow
lymphoid
tissu
addit
evid
lung
dc
distinct
major
splenic
dc
lung
dc
fail
express
splenic
dc
marker
recogn
monoclon
antibodi
pollard
lipscomb
rat
mous
anoth
heterogen
marker
fcrii
posit
half
lung
dc
pollard
lipscomb
xia
et
al
interestingli
langerhan
cell
freshli
isol
skin
express
fcrii
downregul
cell
matur
cultur
thu
possibl
fcr
express
lung
denot
popul
similar
freshli
isol
skin
dc
rat
dc
epithelium
line
airway
like
fcr
wherea
parenchym
dc
nearli
uniformli
fcr
murin
dc
epithelium
trachea
also
express
fcrii
sertl
et
al
suggest
possibl
intraepitheli
dc
pois
take
process
antigen
epithelialenviron
interfac
enter
interstitium
traffic
laln
thu
least
interstiti
dc
fail
express
fcr
may
transit
hand
presenc
fcrdc
lung
parenchyma
includ
alveolar
septa
may
indic
distinct
immun
function
subset
lung
dc
differ
found
mice
capac
fcr
fcrsubset
stimul
mlr
pollard
lipscomb
howev
rat
fcrpopul
potent
stimul
naiv
cell
mlr
respons
lectin
fcrand
fcr
equal
capabl
present
solubl
particul
antigen
antigensensit
cell
kradin
et
al
interest
later
studi
fcrand
fcr
cell
express
adhes
molecul
kradin
et
al
observ
might
partli
explain
increas
abil
fcrcell
stimul
mlr
eleg
studi
lung
intraepitheli
dc
isol
rat
cell
shown
present
antigen
prime
cell
effici
parenchym
dc
man
enrich
fcr
decreas
abil
lung
cell
enrich
dc
stimul
mlr
although
studi
complic
larg
number
contamin
fcr
macrophag
dc
popul
nevertheless
fcr
posit
use
marker
identifi
subset
lung
dc
major
data
consist
concept
deriv
langerhan
cell
popul
fcr
intraepitheli
dc
may
take
antigen
bronchial
lumen
differenti
cell
stimul
naiv
cell
upon
migrat
drain
lymph
node
dc
tissu
site
origin
bone
marrow
steinman
cultur
precursor
bone
marrow
peripher
blood
use
gmcsf
adult
human
dc
peripher
blood
inaba
et
al
inaba
et
al
thoma
et
al
sallusto
lanzavecchia
one
studi
ia
lung
dc
first
recogn
rat
lung
parenchyma
fetal
life
day
gestat
intraepitheli
dc
present
day
continu
increas
postnat
develop
comparison
fetal
lung
dc
demonstr
effici
adult
dc
stimul
immun
respons
fulli
function
birth
contrast
anoth
studi
fail
detect
ia
dc
rat
lung
epithelium
parenchyma
birth
number
increas
rapidli
week
age
approxim
found
adult
ia
dc
first
observ
nasal
turbin
intens
ia
stain
increas
time
first
trachea
later
lung
parenchyma
compat
environment
exposur
effect
chang
use
anoth
marker
dc
also
detect
cell
author
found
dc
level
lung
fetal
rat
lung
specul
environment
influenc
upregul
ia
express
subsequ
function
cell
consist
specul
ifni
increas
number
la
cell
airway
epithelium
steroid
inhal
decreas
number
rel
control
rat
conflict
find
two
group
may
base
differ
hous
environ
two
group
rat
thu
nelson
collabor
use
dustfre
bed
contrast
mccarthi
et
al
quit
like
utero
influenc
affect
number
function
lung
dc
numer
studi
demonstr
dc
spleen
lymph
node
skin
extraordinarili
potent
abil
immun
recipi
anim
follow
inocul
either
iv
subcutan
knight
et
al
mckinney
streilein
sornass
et
al
lung
dc
use
immun
experiment
anim
date
sever
line
evid
suggest
import
role
uiuo
discuss
locat
within
epithelium
place
optim
posit
take
process
antigen
breach
epitheli
barrier
perivascular
dc
pois
process
antigen
reach
lung
via
vasculatur
studi
shown
splenic
dc
instil
lung
may
reach
laln
havenith
et
ul
puls
antigen
may
induc
immun
respons
havenith
et
al
latter
studi
am
puls
antigen
also
capabl
initi
immun
respons
contrast
dc
heatkil
am
also
abl
immun
suggest
am
stimul
respons
antigen
reprocess
host
apc
addit
explant
lung
dc
gain
abil
stimul
prime
cell
follow
intratrach
deliveri
relev
antigen
last
consist
dynam
activ
epitheli
dc
carri
environment
antigen
laln
irradi
rat
result
loss
resid
dc
hr
reconstitut
tracheal
dc
bone
marrow
precursor
day
lung
dc
sure
play
major
role
regul
lung
immun
discuss
previous
like
regul
multipl
environment
factor
remain
determin
whether
antigen
present
lung
dc
like
result
versu
respons
lung
whether
bypass
dc
immun
host
like
deliv
tolerogen
signal
whether
factor
import
determin
outcom
compart
holt
schonhegrad
steinstreilein
describ
either
evalu
marker
situ
obtain
cell
bal
collagenas
digest
lung
tissu
lung
macrophag
dc
lung
lymphocyt
dynam
popul
capac
enter
leav
lung
depend
influenc
milieu
sever
speci
includ
rat
rabbit
chicken
larg
number
lymphocyt
locat
organ
bronchusassoci
lymphoid
tissu
balt
discuss
howev
balt
constitut
speci
regularli
seen
hamster
mice
human
latter
speci
major
lung
lymphocyt
present
interstitiurn
diffus
scatter
mucosa
alveolar
septa
pleura
also
depend
speci
may
intraepitheli
andor
intravascular
pool
lymphocyt
pabst
popul
lung
lymphocyt
exist
bronchoalveolar
space
recov
bal
anim
kept
specif
pathogenfre
environ
lymphocyt
rang
cell
recov
bal
agostini
et
al
pabst
normal
nonsmok
human
figur
vari
less
daniel
et
al
davidson
et
al
becker
et
al
proport
cell
b
cell
nk
cell
vari
degre
compart
lymphocyt
present
composit
lymphocyt
bal
fluid
gener
repres
proport
cell
includ
cell
b
cell
found
peripher
blood
interestingli
human
differ
phenotyp
function
nk
cell
occur
peripher
blood
alveolu
thu
nk
cell
human
alveoli
fail
express
cytolyt
activ
larg
neg
although
nk
cell
cytolyt
activ
exist
interstitium
rel
high
number
cytolyt
activ
nk
cell
also
exist
interstitium
mice
fifteen
cell
fraction
nylon
wool
column
follow
isol
enzymedigest
lung
express
allotyp
marker
detect
mice
leukocyt
isol
lung
parenchyma
guinea
pig
mice
rat
human
rel
percentag
lymphocyt
vari
varianc
like
depend
strain
anim
whether
kept
specif
pathogenfre
rigor
small
monocyt
exclud
much
data
deriv
examin
wrightgiemsastain
cytospin
prepar
lipscomb
et
al
steinstreilein
et
al
holt
schonhegrad
nicod
et
al
b
flow
cytometr
analysi
cell
b
cell
popul
lung
lymphocyt
indic
rel
proport
b
cell
either
increas
ratio
either
decreas
similar
compar
peripher
blood
abraham
et
al
marathia
et
az
huffnagl
et
al
intraepitheli
lymphocyt
common
gut
mucosa
exist
lung
epithelium
anim
speci
rel
less
common
gut
holt
schonhegrad
fournier
et
al
human
b
cell
found
airway
epithelium
outnumb
cell
fournier
et
al
examin
epithelium
upper
respiratori
tract
nose
cover
tonsil
adenoid
b
cell
cell
found
notabl
cell
occur
aggreg
compris
total
cell
although
gener
cell
express
cup
tcr
graemecook
et
al
studi
examin
cell
isol
human
lung
parenchyma
cell
made
less
cell
abraham
et
al
marathia
et
al
studi
mice
hand
resid
lung
lymphocyt
ap
tcr
presum
cell
cell
increas
follow
aerosol
deliveri
tuberculosi
augustin
et
al
regul
movement
lymphocyt
lung
still
incomplet
understood
nevertheless
increas
inform
role
adhes
molecul
regul
traffic
lymphocyt
springer
investig
begin
unravel
regul
steadyst
movement
cell
lung
well
possibl
preemptiv
signal
occur
inflamm
research
emigr
cell
lung
center
accumul
neutrophil
within
pulmomari
vasculatur
immigr
air
space
lung
cell
like
play
critic
role
develop
acut
respiratori
distress
syndrom
recent
inform
indic
adhes
molecul
pand
eselectin
integrin
play
import
role
accumul
neutrophil
lung
pilewski
albelda
relev
adhes
molecul
like
depend
inflammatori
stimulu
provok
recruit
hellewel
et
al
doerschuk
et
az
doerschuk
mulligan
et
al
regul
lymphocyt
lung
less
well
understood
even
though
mention
evid
exist
lymphocyt
isol
laln
collect
effer
lymphat
laln
predisposit
return
lung
mcdermott
bienenstock
spencer
hall
joel
chanana
sever
studi
demonstr
lymphocyt
isol
lung
lavag
normal
human
predominantli
express
memori
phenotyp
eg
saltini
et
al
becker
et
al
import
marker
naiv
versu
memori
cell
hyaluron
acid
receptor
lselectin
naiv
cell
express
low
level
high
level
lselectin
memori
cell
express
high
level
low
level
lselectin
review
sprent
thu
recognit
memori
cell
accumul
preferenti
lung
issu
becom
stimulu
entri
naiv
cell
fail
accumul
role
naiv
cell
multitud
divers
receptor
continu
recircul
secondari
lymphoid
organ
ie
spleen
lymph
node
antigenbear
apc
interact
appropri
cell
site
apct
cell
interact
result
clonal
expans
subsequ
provid
challeng
tissu
popul
cell
abl
specif
react
protect
host
thu
naiv
cell
receptor
allow
migrat
secondari
lymphoid
organ
butcher
et
al
jutila
contrast
lymphocyt
must
enter
challeng
inflam
tissu
might
expect
express
differ
set
home
receptor
inde
case
although
accumul
markedli
inflam
site
seem
nonspecif
low
level
inflamm
exist
immun
cell
accumul
may
determin
drain
lymph
node
deriv
picker
teleolog
would
effici
way
immun
system
select
redirect
cell
site
need
inde
evid
suggest
memori
lymphocyt
bear
cutan
lymphocyteassoci
antigen
seem
specif
home
skin
review
picker
studi
also
suggest
memori
cell
lung
may
uniqu
set
home
receptor
compar
memori
cell
skin
mucos
site
thu
low
cell
skin
eselectin
cla
lung
memori
cell
eselectin
cla
cell
lung
phenotyp
differ
overal
memori
cell
phenotyp
blood
suggest
might
unidentifi
receptor
lung
cell
specif
select
emigr
lung
import
issu
whether
naiv
lymphocyt
traffic
lung
naiv
cell
migrat
peripher
lymph
node
via
high
endotheli
venul
hev
use
lselectinperipher
lymph
node
addressin
interact
anim
speci
balt
hev
present
thu
anim
naiv
cell
could
enter
lung
avail
primari
immun
respons
develop
site
howev
evid
support
possibl
exist
despit
scanti
inform
migrat
naiv
longterm
memori
b
cell
lung
sever
studi
note
lymphoblast
recent
divid
lymphocyt
tendenc
migrat
inflam
uninflam
lung
daniel
et
az
berman
et
al
locat
mechan
lymphocyt
transmigr
investig
e
organ
balt
macrophag
dc
lymphocyt
diffus
distribut
throughout
compart
lung
addit
anim
speci
examin
least
organ
lymphoid
tissu
may
found
variabl
amount
line
bronchi
bronchiol
structur
recogn
mani
year
first
care
describ
bienenstock
et
al
b
recent
controversi
structur
rais
inabl
readili
detect
speci
thu
rel
rare
normal
human
cat
young
pig
pabst
pabst
first
describ
compar
intestin
peyer
patch
appear
follicl
without
capsul
furthermor
lymphocyt
infiltr
overli
bronchial
epithelium
demonstr
alter
morpholog
compar
adjac
epitheli
cell
origin
describ
bronchial
mucosa
speci
examin
eg
rabbit
guinea
pig
rat
mice
dog
pig
chicken
man
bienenstock
et
al
earli
studi
reveal
neonat
thymectomi
fail
affect
normal
develop
balt
rat
chick
tritiat
thymidin
label
autoradiographi
indic
rapid
cell
prolifer
cell
constitut
balt
bienenstock
et
al
transplant
fetal
lung
extrapulmonari
site
interrupt
develop
balt
although
cellular
suggest
antigen
stimul
requir
full
develop
sinc
earli
studi
two
comprehens
review
summar
morpholog
function
balt
mcdermott
et
al
sminia
et
al
individu
aggreg
balt
bronchusassoci
lymphoid
unit
balu
term
defin
sminia
colleagu
consist
focal
area
b
cell
admix
fibroblast
reticulum
cell
macrophag
interdigit
cell
compar
iaposit
dc
follicular
dendrit
cell
balu
capsul
subcapsular
sinus
affer
lymphat
nevertheless
peripher
sinuslik
lymphat
subsequ
drain
lymph
node
lauweryn
baert
furthermor
arteriol
capillari
venul
includ
high
endothel
venul
hev
otsuki
et
al
structur
balu
demonstr
hev
indic
likelihood
naiv
cell
might
migrat
structur
initi
primari
immun
respons
antigen
transloc
bronchial
lumen
compar
role
peyer
patch
gut
although
earli
studi
fail
demonstr
antigen
could
cross
overli
epithelium
recent
studi
suggest
solubl
antigen
might
transloc
bronchial
lumen
across
epithelium
overli
balu
fournier
et
al
myrvik
ocker
balu
lymphocyt
partit
b
cell
area
central
b
cell
surround
cell
dome
area
underneath
epithelium
mixtur
b
cell
sminia
et
al
balu
igmand
iggbear
cell
present
signific
number
togeth
igaposit
cell
contrast
peyer
patch
iga
cell
predomin
sminia
et
al
rat
balt
examin
monoclon
antibodi
determin
type
cell
present
cdcposit
cell
outnumb
cell
b
cell
aggreg
nearli
cell
cdcposit
cell
sminia
et
al
import
studi
relat
traffic
b
cell
balu
publish
van
der
bruggegamelkoorn
kraal
demonstr
vitro
bind
equal
number
b
lymphocyt
rat
guinea
pig
balu
find
clearli
differ
peyer
patch
bind
b
cell
number
b
cell
bind
much
greater
cell
bind
ratio
five
b
cell
everi
cell
find
correspond
increas
b
cell
peyer
patch
rel
number
b
cell
balu
crawford
miller
taken
togeth
studi
indic
specif
hev
balu
differ
peyer
patch
close
resembl
specif
hev
mesenter
lymph
node
van
der
bruggegamelkoorn
kraal
import
address
issu
similar
balt
gutassoci
lymphoid
tissu
balt
promin
certain
speci
includ
chicken
rabbit
rat
clearli
much
less
promin
speci
includ
man
member
speci
balt
may
complet
absent
pabst
nevertheless
even
man
studi
shown
birth
gradual
increas
loos
aggreg
lymphoid
cell
collect
beneath
epithelium
particularli
point
bifurc
bronchi
man
mous
hamster
collect
lymphoid
cell
involv
epithelium
modifi
epithelium
aggreg
view
rel
lack
promin
structur
certain
speci
suggest
role
protect
immun
respons
lung
essenti
sinc
import
function
gut
structur
initi
iga
respons
possibl
lack
wellorgan
balt
speci
predict
local
initi
iga
respons
requir
health
also
suggest
common
mucos
system
iga
b
cell
precursor
develop
gut
migrat
lung
may
function
success
protect
host
lung
infect
sinc
late
investig
systemat
explor
mechan
develop
immun
respons
particul
solubl
protein
antigen
lung
pepi
major
impetu
understand
caus
hypersensit
lung
diseas
asthma
hypersensit
pneumon
develop
individu
other
although
antigen
exposur
model
examin
immun
respons
variou
respiratori
antigen
develop
mani
anim
strain
includ
mice
rat
hamster
guinea
pig
ferret
dog
monkey
hors
cattl
antigen
deliv
via
aerosol
intranas
intratrach
intrabronchi
instil
end
point
immun
experiment
anim
gener
measur
assess
develop
hypersensit
diseas
clinic
morpholog
measur
serum
bronchoalveolar
antibodi
character
aspect
cellmedi
immun
cmi
migrat
inhibit
delayedtyp
hypersensit
dth
via
skin
test
lymphoprolifer
richerson
newhous
et
al
kaltreid
kazmierowski
et
al
ganguli
waldman
among
import
find
earli
studi
solubl
antigen
instil
lung
contrast
particul
antigen
often
fail
produc
immunolog
lung
damag
schatz
et
al
fink
solubl
antigen
repeatedli
instil
lung
could
lead
local
toler
ratzjczak
et
al
holt
leiver
interpret
earli
studi
benefit
current
perspect
type
immun
respons
develop
ie
cmi
versu
antibodi
includ
predomin
isotyp
antibodi
regul
cytokin
secret
cell
cell
present
site
antigen
deposit
mosmann
coffman
recent
studi
expand
import
concept
deriv
earlier
studi
focus
regulatori
mechan
develop
lung
immun
order
understand
variou
form
antigen
might
reach
immun
apparatu
therefor
antigen
clearanc
discuss
b
cell
immun
clearli
interdepend
studi
focus
measur
specif
cell
respons
versu
immunoglobulin
synthesi
respons
noninfecti
lung
antigen
summar
model
specif
examin
lung
respons
infecti
agent
alloantigen
lead
hypersensit
diseas
cover
later
mani
studi
shown
laln
respons
primari
immun
respons
lung
immun
bice
et
al
kaltreid
et
al
steinstreilein
hart
lipscomb
et
al
laln
function
effect
filter
remov
particul
materi
clear
lower
respiratori
tract
via
lymphat
brain
et
az
green
et
al
morrow
although
laln
larg
respons
induct
immun
primari
immun
mechan
respons
clearanc
antigen
lung
laln
complet
understood
antigen
deposit
lung
clear
phagocytosi
am
neutrophil
transport
foreign
materi
mucociliari
escal
lung
although
antigen
transport
laln
immun
respons
produc
least
latter
antigen
carri
free
lymphat
fluid
appar
occur
circumst
limit
inflamm
lauweryn
baert
induct
pulmonari
inflamm
antigen
exposur
appear
particularli
import
transloc
immunogen
lung
laln
exposur
lung
noninflammatori
dose
antigen
often
fail
induc
immun
respons
yoshizawa
et
al
bice
et
al
possibl
immun
respons
airway
antigen
requir
dose
overwhelm
normal
phagocyt
clearanc
mechan
bice
muggenburg
bice
et
al
observ
elev
immun
respons
produc
laln
antigen
deposit
lung
anim
inhal
inflammagen
support
import
pulmonari
inflamm
transloc
antigen
lung
laln
bice
et
al
possibl
inflamm
may
also
alter
rel
proport
antigen
reach
laln
cell
oppos
antigen
free
lymphat
fluid
dog
inocul
via
airway
sheep
red
cell
larg
number
neutrophil
enter
lung
vasculatur
peak
respons
day
instil
antigen
furthermor
neutrophil
phagocyt
particl
alveoli
migrat
laln
carri
particl
harmsen
et
al
am
also
phagocyt
particl
lung
transport
laln
corri
et
al
harmsen
et
al
rel
contribut
neutrophil
transloc
antigen
lung
laln
known
howev
neutrophil
phagocyt
particl
reach
laln
earlier
am
may
import
antigen
transport
laln
am
antigen
transport
laln
may
releas
neutrophil
am
reprocess
resid
apc
initi
pulmonari
immun
addit
am
neutrophil
previous
discuss
lung
dc
also
like
carri
antigen
laln
recent
studi
puls
splenic
dc
inocul
trachea
capabl
immun
host
support
concept
havenith
et
al
whether
antigen
lung
dc
initi
differ
type
helper
subset
respons
antigen
arriv
phagocyt
free
lymph
determin
nevertheless
lung
inflamm
enhanc
transport
antigen
lung
laln
possibl
inhal
materi
induc
pulmonari
inflamm
might
lead
increas
recognit
airborn
antigen
thu
pulmonari
inflamm
caus
inhal
pollut
osebold
et
al
passiv
cigarett
smoke
murray
morrison
ehrlich
et
al
might
increas
immun
recognit
allergen
respons
increas
rate
asthma
evan
et
al
plattsmil
et
al
addit
inflamm
induc
pulmonari
viral
infect
may
also
import
induct
immun
low
level
environment
antigen
eg
allergen
respons
asthma
castleman
et
al
duff
et
al
b
cellmedi
lung
immun
sever
import
question
relat
develop
cmi
lung
includ
antigen
instil
lung
caus
local
andor
system
cmi
form
antigen
ie
solubl
particul
express
viabl
microorgan
influenc
outcom
iv
subcutan
inocul
similar
antigen
gener
similar
degre
cmi
lung
redirect
immun
cell
back
lung
inocul
antigen
lung
result
local
system
cmi
kaltreid
discuss
previous
solubl
particul
antigen
induc
immun
solubl
antigen
induc
less
easili
detect
cmi
respons
similar
antigen
deliv
particul
form
shown
experi
either
solubl
aggreg
human
serum
albumin
use
immunogen
burrel
hill
hill
burrel
infecti
organ
replic
situ
even
capabl
produc
cmi
local
system
waldman
et
al
spencer
et
al
ganguli
waldman
lipscomb
et
al
hapten
trinitrobenzen
steinstreilein
metal
parker
turk
beryllium
oxid
may
also
induc
cmi
lung
follow
direct
instil
appropri
anim
model
hapten
metal
agent
lead
sensit
human
expos
agent
workplac
associ
hypersensit
reaction
number
earli
studi
address
issu
whether
subcutan
iv
direct
lung
instil
antigen
result
differ
express
cmi
three
separ
studi
guinea
pig
inject
via
lung
human
yglobulin
hgg
dnphgg
heatkil
influenza
viru
accumul
specif
cell
among
lymphocyt
recov
lung
measur
migrat
inhibit
factor
releas
antigeninduc
lymphoprolifer
assay
howev
subcutan
iv
inject
antigen
fail
result
measur
specif
cell
accumul
lung
although
system
cmi
could
measur
lymphocyt
node
drain
subcutan
inocul
site
spleen
waldman
henney
nash
holl
lipscomb
et
al
howev
initi
mild
inflammatori
respons
lung
result
accumul
immun
cell
lung
anim
immun
via
extrapulmonari
rout
waldman
et
al
nash
holl
lipscomb
et
al
use
live
attenu
rubella
vaccin
anoth
live
strain
rubella
viru
kinet
local
cmi
respons
studi
follow
inocul
guinea
pig
either
subcutan
intranas
inocul
morag
et
al
studi
migrat
inhibit
factor
activ
paramet
measur
cmi
respons
initi
detect
lung
week
immun
peak
week
longer
detect
week
primari
immun
respons
gener
laln
stimulu
recruit
cell
back
lung
lymphoblast
rapidli
exit
lymph
node
develop
immun
respons
joel
chanana
cell
enter
circul
control
adhes
molecul
local
gener
chemotact
adhes
moleculestimul
cytokin
recruit
inflam
lung
berman
et
al
previous
discuss
although
markedli
inflam
lung
nonspecif
recruit
cell
b
cell
memori
cell
gener
laln
may
also
home
molecul
specif
direct
return
lung
import
factor
retain
recruit
immunespecif
cell
continu
presenc
specif
antigen
within
tissu
least
two
group
shown
occur
lipscomb
et
al
lyon
lipscomb
emeson
et
al
thu
cell
blast
enrich
two
differ
antigen
label
two
distinguish
radioisotop
shown
retain
lung
lobe
nonspecif
addit
select
lung
lobe
contain
relev
antigen
lipscomb
et
al
select
retent
induc
antigen
carri
apc
deposit
lung
class
mhc
restrict
suggest
cell
retain
lung
lobe
bind
apc
vivo
studi
ad
valid
concept
four
gener
mechan
relat
recruit
retent
immun
cell
lung
recent
activ
b
cell
ie
lymphoblast
lymphoid
tissu
nonspecif
recruit
inflam
lung
cell
recent
activ
laln
express
adhes
molecul
uniqu
design
target
bind
lung
endothelium
matrix
lung
parenchym
cell
adhes
molecul
express
control
local
environment
perturb
facilit
emigr
immun
cell
antigen
express
appropri
mhc
lung
lead
preferenti
retent
expans
lung
specif
recruit
b
cell
shown
see
presenc
retain
antigen
specif
helper
cell
recruit
specif
b
cell
could
divid
differenti
c
b
celldepend
lung
immun
antigenspecif
antibodi
produc
laln
primari
lung
immun
releas
blood
bice
et
az
shopp
bice
addit
larg
number
antigenspecif
igg
iga
igm
afc
produc
laln
also
enter
blood
lung
immun
sevral
speci
eg
dog
cynomolgu
monkey
chimpanze
human
bice
et
al
kaltreid
et
al
mason
et
al
weissman
et
al
studi
larger
anim
afc
blood
recruit
lung
lobe
expos
antigen
significantli
fewer
afc
found
lung
lobe
anim
expos
salin
noth
appear
two
factor
control
entri
afc
lung
first
afc
must
recent
produc
immun
respons
lymphoid
tissu
produc
exert
control
entri
lung
afc
produc
poplit
lymph
node
enter
lung
rate
afc
produc
laln
hillam
et
al
second
afc
enter
site
inflamm
produc
instil
antigen
lung
bice
et
al
hillam
et
al
howev
recruit
afc
inflammatori
site
lung
antigen
specif
also
enter
lung
lobe
inflam
instil
particl
inflammatori
agent
plasma
cell
found
alveoli
interstiti
lung
tissu
immun
lung
lobe
suggestig
afc
enter
lung
matur
plasma
cell
bice
et
al
antigenspecif
igm
igg
iga
antibodi
lung
primari
exposur
antigen
produc
local
cell
hill
et
al
afc
control
lung
lobe
expos
salin
also
activ
produc
antigenspecif
antibodi
bice
et
al
result
sever
studi
show
afc
lung
primari
immun
recruit
lung
produc
local
mason
et
al
bice
et
al
addit
cell
number
amplifi
interact
antigen
might
retain
lung
primari
immun
bice
et
al
addit
afc
larg
number
lymphocyt
enter
lung
peak
respons
occur
day
immun
mean
total
lavag
cell
lymphocyt
speci
differ
exist
releas
afc
blood
laln
recruit
afc
lung
dog
bice
et
al
nonhuman
primat
bice
et
al
mason
et
al
human
steven
et
al
lue
et
al
weissman
et
al
larg
number
afc
blood
immun
blood
afc
enter
lung
contrast
data
singl
immun
lung
rat
guinea
pig
rabbit
mice
suggest
afc
releas
blood
rel
afc
appear
subsequ
lung
bice
shopp
howev
use
adjuv
larg
dose
antigen
appear
increas
number
afc
lung
guinea
pig
mice
shopp
bice
curti
kaltreid
possibl
strain
speci
evalu
may
also
import
although
data
avail
compar
pulmonari
b
cell
respons
differ
strain
laboratori
anim
although
primari
immun
respons
produc
lung
independ
secondari
lymphoid
tissu
data
suggest
memori
respons
may
detect
lung
antigen
challeng
independ
laln
mason
et
al
ada
bice
et
al
logic
explan
product
afc
antibodi
lung
antigen
challeng
immun
memori
cell
recruit
andor
develop
lung
primari
immun
unlik
primari
immun
respons
specif
igg
iga
antibodi
produc
immun
lung
rechalleng
antigen
appear
come
local
immun
memori
b
cell
local
product
afc
rather
afc
recruit
lung
blood
minim
specif
igm
produc
lung
antigen
rechalleng
bice
et
al
specif
antibodi
continu
produc
lung
sever
year
last
exposur
antigen
bice
et
al
lavag
fluid
immun
challeng
lung
lobe
contain
significantli
specifi
igg
sever
year
last
exposur
antigen
present
lavag
fluid
control
lung
lobe
thu
intens
local
antibodi
respons
establish
lung
immun
mechan
support
continu
local
antibodi
product
sever
year
last
exposur
antigen
site
antigen
exposur
although
afc
identifi
lavag
fluid
expos
lung
lobe
sever
year
antigen
challeng
possibl
cell
interstiti
lung
tissu
well
laln
distant
lymphoid
tissu
import
longterm
antibodi
product
howev
evalu
antibodi
product
lung
variou
extrapulmonari
tissu
show
longterm
antibodi
product
occur
interstiti
tissu
immun
lung
lobe
cell
control
lung
lobe
tissu
laln
receiv
lymphat
drainag
immun
lung
lobe
spleen
gutassoci
lymph
node
poplit
lymph
node
produc
signific
level
antibodi
year
last
antigen
challeng
therefor
immun
cell
retain
lung
tissu
previous
expos
antigen
may
import
sourc
antibodi
protect
lung
addit
absenc
antibodi
product
laln
distant
lymphoid
tissu
suggest
antibodi
produc
lung
tissu
expos
antigen
could
possibl
enter
bloodstream
provid
immun
protect
unexpos
lung
lobe
extrapulmonari
tissu
two
possibl
mechan
could
respons
longterm
antibodi
product
lung
lobe
previous
expos
antigen
first
antigen
retain
lung
possibl
follicular
dendrit
cell
could
stimul
antibodi
product
antigenspecif
memori
b
lymphocyt
migrat
lung
altern
b
lymphocyt
recruit
produc
lung
respons
initi
antigen
challeng
might
live
sever
year
continu
secret
antibodi
continu
antibodi
product
occur
lung
lobe
expos
antigen
antigen
depot
may
essenti
data
publish
support
possibl
tew
et
al
peeter
carter
summari
studi
suggest
pulmonari
humor
immun
maintain
continu
longterm
spontan
antibodi
product
antigen
challeng
restimul
local
pulmonari
memori
b
cell
secret
antibodi
despit
abil
lung
express
natur
acquir
immun
respiratori
tract
infect
common
type
infect
experienc
human
certainli
common
cold
alon
win
competit
hand
vaccin
power
intervent
protect
mani
respiratori
tract
infect
includ
bacteria
bordetella
pertussi
corynebacteria
diphtheria
hemophilu
influenza
streptococcu
pneumonia
tuberculosi
virus
includ
one
viru
primarili
infect
respiratori
tract
ie
influenza
sever
initi
infect
via
respiratori
tract
rubeola
rubella
mump
major
impetu
current
research
infecti
diseas
learn
natur
host
defens
infect
immun
system
amplifi
defens
mason
nelson
better
understand
strategi
hope
optim
vaccin
immunocompet
host
perhap
even
host
immunosuppress
yet
retain
capac
respond
immunolog
altern
immunosuppress
individu
better
abl
understand
immunolog
deriv
cytokin
function
normal
host
infect
recombin
form
might
administ
replac
use
anim
model
consider
enhanc
understand
lung
infect
role
immun
control
pneumonia
caus
extracellular
bacteria
recruit
phagocyt
opsonin
especi
antibodi
complement
requir
effect
control
infect
even
antibiot
use
thu
goal
vaccin
pneumonia
rais
level
local
antibodi
chronic
pneumonia
pneumonia
caus
intracellular
microorgan
goal
vaccin
less
clear
although
protect
virus
list
previous
correl
serum
antibodi
level
best
evid
support
probabl
enhanc
cmi
would
protect
immun
mani
oblig
facult
intracellular
bacteria
fungi
parasit
lipscomb
campbel
section
exampl
anim
model
infecti
diseas
address
pulmonari
immun
develop
variou
etiolog
agent
discuss
type
immun
afford
protect
indic
investig
use
experiment
model
studi
nearli
infecti
agent
produc
respiratori
infect
space
dictat
repres
studi
includ
administr
pneumonia
lung
lead
rapid
accumul
neutrophil
alveolar
space
develop
local
inflammatori
respons
pneumonia
pulmonari
infect
note
earli
histopatholog
studi
loosli
wood
loosli
subsequ
studi
confirm
requir
intact
granulocyt
function
host
erad
pulmonari
infect
wood
et
al
heidbrink
et
al
studi
examin
mechan
respons
neutrophil
recruit
earli
stage
pneumonia
pulmonari
infect
bruyn
et
al
sever
group
demonstr
anim
system
decompl
cobra
venom
factor
impair
abil
recruit
neutrophil
clear
organ
bronchoalveolar
space
role
recruit
neutrophil
respons
intratrach
deliv
pneumonia
assess
use
congen
mice
result
indic
import
produc
optim
earli
neutrophil
recruit
bacteri
clearanc
respons
pneumonia
chemotaxin
must
involv
chemotact
activ
neutrophil
recruit
found
phagocyt
effector
cell
recruit
lung
neutrophil
macrophag
requir
opsonin
immunoglobulin
complement
effici
phagocytosi
pneumonia
guckian
et
al
coonrood
yoneda
presenc
surfac
pneumococci
vital
phagocytosi
deposit
pneumonia
either
classic
complement
pathway
interact
antibodi
altern
complement
pathway
winkelstein
joiner
et
al
streptococcu
pneumonia
kill
initi
pulmonari
inflammatori
reaction
drain
laln
eventu
enter
system
circul
result
bacterem
phase
austrian
phase
typespecif
antibodi
capsular
polysaccharid
produc
demonstr
passiv
immun
studi
presenc
typespecif
antibodi
igg
igm
serum
protect
sever
pneumococc
infect
musher
et
al
nontypespecif
antibodi
pneumonia
made
infect
includ
antibodi
cell
wall
compon
brown
et
al
surfac
protein
szu
et
al
f
polysaccharid
au
eisenstein
gener
anim
studi
indic
latter
antibodi
play
minim
role
provid
effect
protect
infect
pneumonia
szu
et
al
brown
et
al
role
secretori
iga
prevent
pneumococc
diseas
unclear
although
one
mous
model
demonstr
pneumoniaespecif
iga
could
arm
lung
lymphocyt
subsequ
demonstr
antibacteri
action
pneumonia
sestini
et
al
iga
report
fix
complement
act
opsonin
hiemstra
et
al
gorter
et
al
thu
could
play
role
prevent
pneumonia
infect
final
humor
factor
antibodi
implic
protect
pneumonia
particularli
creactiv
protein
activ
complement
act
opsonin
bound
capsul
although
role
creativ
protein
demonstr
clear
pneumonia
bloodstream
volanaki
kaplan
horowitz
et
al
role
creactiv
protein
pulmonari
stage
infect
demonstr
model
acut
pulmonari
infect
h
influenza
develop
rat
wallac
et
al
mous
esposito
pennington
toew
et
al
latter
method
deliv
reproduc
bolu
organ
lower
respiratori
tract
via
endobronchi
cathet
use
techniqu
determin
clearanc
typabl
nontyp
h
influenza
lung
occur
similar
rate
clearanc
organ
appear
occur
two
phase
initi
hr
postinocul
organ
increas
number
threeto
fivefold
next
hr
organ
rapidli
clear
toew
et
al
studi
indic
rapid
clearanc
phase
correspond
influx
neutrophil
lung
presenc
leukocyt
vital
effect
clearanc
toew
et
al
effect
specif
antibodi
h
inuenza
rate
pulmonari
clearanc
examin
use
activ
immun
passiv
administr
immun
sera
result
indic
presenc
specif
antibodi
serum
bal
fluid
immun
mice
correl
increas
rate
clearanc
lung
system
igc
could
provid
protect
lower
respiratori
tract
anim
also
demonstr
experi
show
enhanc
clearanc
h
influenza
lung
mice
receiv
immun
sera
taken
togeth
result
indic
presenc
elev
titer
serum
igg
protect
antibodi
could
enter
airway
infect
lung
provid
protect
pulmonari
pathogen
contrast
organ
discuss
previous
previou
immun
aureu
appear
enhanc
clearanc
provid
protect
antibodi
pulmonari
infect
jakab
recent
studi
suggest
pulmonari
clearanc
organ
may
depend
local
produc
opsonin
enhanc
phagocytosi
surfact
protein
produc
type
pneumocyt
bind
aureu
increas
phagocytosi
protein
enhanc
uptak
pneumonia
mcneeli
coonrood
lung
infect
two
microorgan
mtb
cryptococcu
neoforman
cne
discuss
section
exampl
infect
requir
intact
cmi
resolut
anim
model
chronic
lung
infect
sever
import
pathogen
organ
studi
includ
pneumocysti
carinii
walzer
et
al
harmsen
stankiewicz
boylan
current
histoplasma
capsdatum
baughman
et
al
defaveri
graybil
fojtasek
et
al
allendoerf
et
al
blastomyc
dermitid
morozumi
et
al
moser
et
al
frey
et
al
william
et
al
paracoccidiod
braziliensi
brummer
et
al
defaveri
et
al
coccidiod
immiti
cox
et
al
chlamydia
trachomati
psittaci
rhodococcu
equi
kanali
et
al
mycobacterium
auiumintracellular
takashima
collin
although
infect
legionella
pneumophila
caus
acut
pneumonia
suscept
host
facult
intracellular
bacterium
cmi
thought
necessari
resolut
infect
anim
model
studi
infect
also
develop
skerrett
martin
central
role
cmi
cell
recruit
activ
macrophag
control
intracellular
bacteri
infect
first
propos
georg
macka
use
listeria
monocytogen
murin
infect
model
macka
find
import
role
cmi
control
aerogen
listeria
infect
mice
mackanew
extend
studi
propos
cellmedi
hypersensit
might
import
caus
lung
diseas
macka
howev
collabor
observ
contrast
protect
afford
activ
immun
adopt
transfer
listeria
immun
splenocyt
seem
afford
minor
protect
aerosol
infect
truitt
macka
retrospect
adopt
immun
might
transfer
success
laln
lung
lymphocyt
aerosolinfect
mice
use
instead
spleen
cell
system
immun
mice
latter
cell
like
home
ineffici
infect
lung
huffnagl
et
al
nevertheless
experi
virul
mtb
organ
given
iv
lung
develop
effect
resist
although
less
effect
spleen
liver
macka
earli
studi
suggest
cmi
lung
might
rigidli
downregul
perhap
prevent
excess
damag
delic
structur
howev
macka
offer
addit
explan
eg
lung
infect
mtb
may
difficult
control
local
organ
sequest
macrophag
contrast
recruit
monocyt
might
resist
activ
signal
deliv
cell
role
pulmonari
immun
mtb
infect
analyz
varieti
anim
model
smith
wiegehau
includ
rabbit
luri
mice
orm
collin
north
izzo
guinea
pig
initi
experi
involv
intranas
intratrach
inocul
develop
middlebrook
chamber
middlebrook
provid
mean
aerosol
mtb
anim
earli
studi
examin
number
mtb
requir
reproduc
infect
anim
mice
expos
mist
virul
mtb
develop
discreet
lesion
progress
fatal
week
period
schwabach
wilson
initi
studi
extend
compar
aerosol
versu
intranas
deliveri
mtb
found
rout
produc
similar
patholog
observ
deposit
inoculum
organ
requir
reproduc
infect
dose
approxim
organ
result
death
glover
resid
undoubtedli
play
role
mtb
infect
mtb
deposit
lung
rapidli
taken
evid
role
defens
mtb
partli
come
epidemiolog
studi
examin
mtb
infect
individu
silicosi
snyder
silica
exposur
result
uptak
silica
particl
silica
particl
remain
phagolysosom
throughout
life
individu
allison
dacci
hart
like
affect
function
essenti
epidemiolog
studi
examin
incid
mtb
infect
silicaexpos
popul
conclud
incid
mtb
infect
group
significantli
higher
incid
mtb
infect
nonsilicaexpos
popul
snyder
sever
studi
shown
human
andor
mous
stimul
produc
chemotact
factor
cytokin
respons
mtb
compon
mtb
cell
wall
barn
et
al
chatterje
et
al
releas
product
may
repres
earli
nativ
defens
system
mtb
thu
chemotact
factor
act
recruit
neutrophil
monocyt
circul
amreleas
cytokin
tnfa
activ
local
newli
recruit
cell
inde
studi
indic
cytokineactiv
andor
monocyt
inhibit
growth
kill
mtb
crowl
rastogi
deni
recent
data
suggest
macrophag
cytokin
includ
may
enhanc
develop
h
l
subset
lead
protect
immun
hsieh
et
al
data
indic
avirul
mtb
elicit
greater
cytokin
respons
macrophag
virul
mtb
lead
hypothesi
observ
differ
mtb
virul
may
due
intrins
abil
virul
mtb
prevent
decreas
releas
factor
barn
et
al
chatterje
et
al
roach
et
al
ethnic
differ
observ
suscept
mtb
coulta
et
al
might
due
genet
disposit
poor
initi
respons
mtb
role
cmi
demonstr
protect
mtb
infect
suter
leveton
et
al
guinea
pig
model
demonstr
anim
given
low
dose
mtb
organ
replic
log
phase
day
exponenti
growth
ceas
decreas
growth
coincid
onset
tuberculin
skin
test
sensit
develop
detect
bacillemia
bacteriostasi
ensu
next
day
number
mtb
lung
gradual
reduc
although
data
consist
role
develop
acquir
cmi
respons
resolut
mtb
infect
orm
collin
examin
immun
respons
mous
model
direct
evid
provid
role
cell
pulmonari
immun
mtb
seri
adopt
transfer
experi
remov
splenic
cell
mous
receiv
iv
inocul
mycobactelium
bovi
bcg
inject
bcgimmun
cell
thymectom
subleth
irradi
nonimmun
mice
mice
challeng
aerosol
dose
mtb
deposit
organ
lung
two
import
find
studi
adopt
transfer
immun
cell
enhanc
clearanc
mtb
lung
differenti
remov
subset
cell
specif
antisera
skin
test
tuberculin
sensit
dissoci
protect
antitubercul
immun
indic
separ
popul
cell
may
respons
two
event
followup
studi
orm
mtbimmun
cell
adopt
transfer
protect
mice
challeng
lethal
aerosol
inoculum
x
organ
mtb
either
cell
could
transfer
protect
mice
expos
low
dose
organ
mtb
comparison
pulmonari
inocul
studi
model
use
intraperiton
iv
rout
inocul
produc
differ
result
intraperiton
model
mtbreactiv
cell
clone
provid
dth
respons
protect
measur
growth
mtb
peritoneum
pedrazzini
loui
similarli
mtbimmun
cell
clone
provid
protect
measur
reduc
splenic
cfu
follow
iv
mtb
infect
anoth
studi
use
vivo
deplet
cell
subset
demonstr
deplet
cell
decreas
resist
iv
infect
deplet
cell
signific
effect
pedrazzini
et
al
contrast
similar
model
transgen
mice
incap
produc
cell
shown
decreas
resist
mtb
compar
normal
mice
flynn
et
al
role
cell
pulmonari
defens
mtb
unresolv
obrien
et
al
kaufmann
kabelitz
cell
releas
ifni
tempt
specul
cell
repres
initi
defens
mechan
lung
provid
activ
cytokin
enhanc
local
effector
mechan
help
control
infect
develop
protect
immun
ap
cell
initi
studi
demonstr
increas
number
lung
cell
intratrach
dose
ppd
jani
et
al
studi
suggest
mani
cell
respond
heatshock
protein
mtb
born
et
al
kaufmann
kabelitz
studi
suggest
may
play
role
granuloma
format
modlin
et
al
howev
human
activ
mtb
infect
increas
cell
granuloma
determin
immunohistochem
stain
tazi
et
al
work
anim
model
human
natur
infect
requir
defin
role
cell
mucos
immun
particularli
regard
role
mtb
infect
complex
interact
exist
develop
protect
immun
cell
type
cytokin
produc
infect
similar
studi
show
import
protect
role
h
l
cell
preferenti
secret
ifni
leishmania
infect
locksley
et
al
like
mechan
product
appropri
cytokin
critic
develop
protect
immun
mtb
flesch
deni
kawamura
et
al
barn
et
al
orm
et
al
well
mainten
resist
state
chronic
infect
stage
import
role
ifni
mtb
resist
recent
demonstr
aerosol
iv
mtb
infect
model
compar
infect
normal
ifni
knockout
mice
cooper
et
al
flynn
et
al
demonstr
lack
ifni
result
signific
increas
mtb
suscept
howev
sinc
ifni
absent
throughout
cours
infect
unclear
stage
immun
respons
ifni
requir
flynn
et
al
inde
ifni
may
import
aspect
respons
mtb
includ
cell
develop
cell
recruit
activ
effector
mechan
studi
mice
examin
granulomat
respons
ivinject
bcg
anim
receiv
neutral
antibodi
tnfa
kindler
et
al
studi
amiri
et
al
indic
tnfa
also
play
critic
role
protect
tb
particularli
develop
mainten
granuloma
attempt
vaccin
anim
avirul
kill
mtb
provid
import
data
regard
potenti
vaccin
gener
studi
suggest
enhanc
immun
respons
virul
mtb
viabl
organ
must
use
larson
wicht
rout
immun
viabl
organ
either
iv
aerosol
vaccin
prevent
infect
rather
limit
tissu
destruct
degre
hematogen
dissemin
immun
nonviabl
cellular
element
afford
protect
summari
develop
protect
immun
pulmonari
infect
mtb
requir
coordin
activ
multipl
cell
type
particularli
macrophag
cell
continu
studi
ofth
mtb
pulmonari
infect
aid
understand
mechan
develop
effect
cmi
lung
suggest
strategi
enhanc
pulmonari
defens
cne
encapsul
yeast
found
desicc
form
soil
particularli
area
contamin
pigeon
fece
cne
usual
caus
asymptomat
infect
human
follow
inhal
normal
individu
typic
clear
organ
suscept
particularli
defect
cmi
organ
may
dissemin
via
bloodstream
produc
extrapulmonari
infect
usual
mening
mice
use
experiment
model
studi
host
defens
microorgan
capsul
resist
endocytosi
thu
typic
replic
tissu
extracellular
locat
murin
model
organ
frequent
inocul
iv
ip
although
establish
mani
year
ago
mice
hous
contamin
bed
smith
et
al
expos
aerosol
karaoui
et
al
receiv
intranas
inocul
organ
ritter
larsh
develop
infect
earli
studi
valid
concept
organ
acquir
respiratori
tract
murphi
colleagu
contribut
substanti
understand
immun
natur
defens
mechan
protect
yeast
demonstr
anim
inocul
intranas
develop
pulmonari
infect
dissemin
follow
develop
dth
gradual
clear
infect
lim
et
al
furthermor
investig
demonstr
transfer
cellenrich
splenocyt
mice
immun
intranas
infect
capabl
protect
mice
iv
challeng
lim
et
al
import
studi
passiv
transfer
serum
fail
protect
mice
other
develop
intratrach
inocul
infect
model
cne
studi
pulmonari
immun
mechan
mice
hill
harmsen
huffnagl
et
al
huffnagl
lipscomb
model
organ
inocul
small
amount
directli
trachea
yeast
lung
quantit
homogen
organ
measur
colonyform
unit
cfu
initi
day
organ
grow
rapidli
follow
gradual
decreas
cfu
appropri
mous
strain
process
refer
lung
clearanc
huffnagl
lipscomb
import
aspect
model
true
mani
lung
infect
model
strain
ofmicroorgan
strain
mous
determin
whether
infect
clear
lung
rate
huffnagl
et
al
studi
use
rel
low
virul
encapsul
yeast
athym
nude
mice
mice
sever
combin
immunodefici
scid
mice
deplet
cell
incap
pulmonari
clearanc
huffnagl
et
al
b
huffnagl
lipscomb
hill
harmsen
furthermor
protect
lung
adopt
transfer
scid
mice
splenic
lymphocyt
adopt
immun
effect
lymphocyt
isol
lung
laln
anim
immun
lung
infect
use
huffnagl
et
al
interestingli
use
virul
organ
cell
respons
increas
resist
highli
virul
organ
follow
extrapulmonari
spread
demonstr
effect
control
infect
within
lung
modi
et
al
latter
studi
demonstr
earlier
studi
macka
dichotomi
abil
immun
anim
demonstr
effect
immun
lung
compar
extrapulmonari
organ
role
cell
immun
protect
absenc
either
reduc
number
inflammatori
cell
includ
macrophag
even
profoundli
decreas
absent
huffnagl
et
al
role
cell
repeatedli
shown
strain
mice
demonstr
acquir
resist
lowvirul
cne
ie
balbc
congen
balbc
igh
locu
mice
cba
mice
hill
harmsen
huffnagl
et
al
modi
et
al
role
cell
infect
particularli
curiou
although
cell
clearli
particip
develop
immun
intracellular
organ
mechan
propos
includ
secret
ifni
lysi
infect
target
follow
recognit
cell
peptid
context
class
mhc
kaufmann
howev
known
cell
function
murin
cne
diseas
organ
primarili
extracellular
one
import
mechan
may
relat
capac
enhanc
either
clonal
expans
recruit
cell
lung
huffnagl
et
al
thu
cell
deplet
cneinfect
mice
reduc
number
cell
infect
lung
second
role
may
relat
find
lung
cell
isol
celldeplet
anim
capabl
secret
ifni
mitogenstimul
cultur
suggest
cell
set
could
also
contribut
ifni
product
play
role
macrophag
activ
also
demonstr
cell
play
critic
role
develop
dth
cne
cneinfect
mice
could
adopt
transfer
dth
import
observ
prove
cell
recogn
antigen
extracellular
organ
context
class
mhc
thu
possibl
cell
might
lyse
phagocytos
organ
kill
activ
macrophag
effector
cell
may
play
role
mice
particularli
adept
develop
h
l
respons
character
clear
cne
lung
abil
relat
enhanc
secret
ifni
laln
cell
earli
infect
heighten
resist
mice
correl
express
induc
nitric
oxid
synthas
ino
gene
lung
accompani
secret
lung
cell
earli
clearanc
phase
complet
abrog
antiifni
treatment
feed
anim
inhibitor
product
lovchik
et
al
thu
mice
clearanc
lung
relat
capac
anim
make
ifni
cell
necessari
protect
lung
cne
infect
effector
mechan
mediat
mainli
activ
macrophag
answer
question
still
uncertain
rat
activ
ifni
abl
inhibit
growth
cne
modi
et
al
furthermor
prolong
incub
gmcsf
also
activ
cne
growth
inhibit
murin
macrophag
peritoneum
bcgimmun
mice
inhibit
growth
cne
vitro
argininedepend
mechan
relat
product
granger
et
al
alspaugh
granger
consist
vivo
data
lovchik
import
aspect
growth
inhibit
nodepend
mechan
requir
endocytosi
although
endocytosi
enhanc
growth
inhibit
granger
et
al
other
demonstr
ifnyactiv
mous
macrophag
kill
cne
determin
secret
protein
import
flesch
et
al
activ
human
macrophag
make
littl
unlik
rat
mous
macrophag
leav
open
question
effector
mechan
human
macrophag
may
use
growth
inhibit
cne
human
neutrophil
macrophag
inhibit
growth
kill
cne
cultur
includ
fresh
complement
miller
mitchel
organ
fix
complement
altern
pathway
result
bind
yeast
capsul
allow
phagocytosi
neutrophil
macrophag
kozel
pfrommer
kozel
et
al
mechan
shown
play
import
role
clear
cne
pulmonari
vasculatur
fungem
state
mice
lovchik
lipscomb
howev
cne
tissu
tend
provok
brisk
inflamm
bronchoalveolar
space
cerebrospin
fluid
contain
signific
complement
furthermor
may
express
thu
cell
must
amplifi
effector
system
recruit
andor
activ
nonspecif
effector
becom
direct
effector
recent
studi
indic
human
nk
cell
cell
direct
activ
vitro
cne
levitz
et
al
murphi
et
al
although
conflict
evid
human
nk
cell
growthinhibit
activ
unless
antibodi
organ
present
miller
et
al
demonstr
murin
nk
cell
minor
effect
organ
follow
iv
inocul
fail
play
role
earli
lung
clearanc
organ
inocul
via
trachea
recent
cellindepend
partial
protect
host
defens
mechan
found
lung
clearanc
scid
mice
balbc
mice
deplet
athyl
asialogmlcel
respons
hill
dunn
studi
clearli
indic
examin
role
cell
anim
model
identifi
origin
particularli
view
possibl
import
cell
human
cne
infect
histolog
examin
murin
lung
clearanc
phase
demonstr
yeast
surround
macrophag
activ
appear
hill
huffnagl
lipscomb
appear
similar
seen
lung
human
cryptococcoma
known
abl
resolv
infect
without
antibiot
therapi
lung
becom
inflam
complement
avail
neutrophil
may
play
role
kill
cne
lung
although
rel
import
neutrophil
cell
activ
macrophag
remain
clarifi
continu
studi
use
murin
cne
lung
infect
model
help
elucid
mechan
lead
develop
thllike
respons
laln
earli
infect
subsequ
recruit
lymphocyt
macrophag
lung
closer
examin
effector
mechan
work
lung
anim
clear
cne
infect
particularli
resist
mous
strain
may
util
activ
macrophag
may
help
elucid
host
defens
mechan
man
c
viral
pneumonia
virus
intracellular
organ
usurp
host
cellular
machineri
replic
viral
entri
cell
block
antibodi
howev
insid
cell
viru
resist
antibodi
cell
recognit
viral
peptid
present
context
class
mhc
antigen
cell
surfac
allow
specif
cytotox
cell
lyse
infect
cell
zinkernagel
viral
replic
ensu
particl
releas
cell
surfac
antibodi
opportun
block
spread
viru
gener
cytotox
cell
play
import
role
control
local
viral
replic
antibodi
prevent
initi
infect
extracellular
spread
within
host
viral
infect
seem
rel
minor
role
cell
zinkernagel
howev
number
viral
infect
mice
deplet
cell
increas
mortal
reduc
rate
clearanc
role
cell
may
relat
provid
help
cytolyt
lymphocyt
ctl
develop
reiss
burakoff
b
cell
product
highaffin
igg
iga
antibodi
role
cell
nk
cell
macrophag
acut
viral
infect
still
clear
furthermor
whether
memori
ctl
play
import
role
prevent
recurr
infect
also
uncertain
zinkernagel
also
uncertain
whether
persist
longterm
memori
b
cell
virus
requir
continu
presenc
viru
viral
particl
zinkernagel
sprent
larg
number
virus
infect
respiratori
tract
includ
rhinovirus
coronavirus
adenovirus
influenza
parainfluenza
virus
respiratori
syncyti
viru
rsv
measl
mump
rubella
virus
good
model
mice
exist
rsv
influenza
infect
discuss
highlight
experiment
model
provid
insight
immun
defens
viral
respiratori
tract
infect
immun
influenza
kill
fraction
viral
antigen
protect
influenza
immun
rsv
problemat
salk
salk
wright
et
al
graham
et
al
alwan
et
al
protect
rsv
produc
bronchiol
infant
common
caus
hospit
infant
western
countri
afford
immun
formalininactiv
viru
subsequ
infect
immun
sometim
result
unusu
sever
infect
even
death
kapikian
et
al
kim
et
al
mechan
unknown
variou
theori
includ
immun
complex
diseas
cellmedi
dth
reaction
ctlmediat
pneumon
graham
et
al
recent
effort
use
rsv
infect
mice
sought
understand
mechan
protect
might
immun
might
lead
enhanc
pathogen
subsequ
challeng
deplet
mice
either
cell
reduc
diseas
lung
follow
initi
rsv
infect
also
enhanc
viru
replic
graham
et
al
thu
control
viral
replic
even
primari
infect
result
lung
patholog
least
two
group
attempt
determin
whether
variou
viral
subunit
might
initi
protect
immun
yet
caus
minim
patholog
mice
vaccin
either
parenter
intranas
inocul
follow
nasal
rsv
challeng
lead
express
cytokin
mrna
lung
graham
et
al
specif
cytokin
mrna
detect
depend
whether
live
heatkil
subunit
vaccin
given
inactiv
viru
subunit
fusion
f
protein
induc
cytokin
express
suggest
lymphocyt
respons
increas
mrna
rel
ifni
express
contrast
mice
prime
parenter
nasal
live
viru
h
l
respons
promin
formalinfix
viru
f
protein
compon
somewhat
protect
howev
effect
protect
induc
immun
intranas
live
viru
furthermor
immun
protocol
result
least
lung
patholog
rechalleng
experi
design
determin
cell
type
caus
patholog
whether
specif
rsv
subunit
evok
specif
pathologyproduc
immun
cell
cell
line
develop
immun
lymphocyt
mice
immun
f
protein
major
surfac
glycoprotein
g
matrix
protein
express
recombin
vaccinia
viru
alwan
et
al
f
protein
lead
develop
ctl
cell
h
l
phenotyp
g
protein
facilit
develop
cell
phenotyp
immun
cell
proteinimmun
mice
result
predominantli
ctl
repres
cell
line
group
transfer
protect
pathogen
effect
rsvinfect
mice
cell
seem
damag
furthermor
combin
line
afford
greatest
protect
thu
protect
often
synonym
patholog
may
difficult
dissoeiat
two
l
clear
time
serum
antibodi
correl
protect
influenza
virus
influenza
virus
exhibit
antigen
drift
shift
requir
individu
immun
yearli
protect
preval
viru
strain
zinkernagel
salk
salk
immun
influenza
success
possibl
new
immun
protocol
might
develop
would
broadli
protect
contrast
b
cell
epitop
cell
epitop
may
crossreact
cytotox
cell
seem
play
import
role
control
influenza
infect
zinkernagel
althag
earli
studi
establish
recoveri
mice
infect
influenza
requir
develop
ctl
respons
viru
protect
afford
adopt
transfer
immun
cell
naiveinfect
host
yap
et
al
lukach
et
al
studi
indic
class
mhcrestrict
cell
clone
could
promot
recoveri
lethal
pulmonari
infect
mcdermott
et
al
cell
clone
preferenti
retain
lung
influenzainfect
mice
independ
viral
antigen
specif
migrat
pulmonari
vessel
bronchiolar
lumen
thu
immun
cell
accumul
site
appropri
provid
protect
viral
challeng
mice
die
within
day
lethal
influenza
infect
array
cytokin
could
detect
bal
fluid
mice
none
unequivoc
indic
cell
respons
hennet
et
al
thu
illa
illp
tnfp
gmcsf
ifni
leukotrien
identifi
lavag
hand
subleth
infect
influenza
infect
resolv
examin
cell
lavag
well
laln
demonstr
cell
cytokin
product
card
et
al
sarawar
et
al
primari
infect
kinet
cytokin
mrna
compat
initi
respons
occur
region
lymph
node
effector
cell
appear
later
lung
among
ap
cell
transcript
ifni
tnfp
predominantli
found
cell
tendenc
appear
cell
interestingli
cell
identifi
express
ifni
secondari
respons
cell
cytokin
mrna
found
almost
simultan
laln
lung
card
et
al
relat
studi
mrna
detect
situ
hybrid
cytokin
product
identifi
individu
cell
elispot
major
cell
lavag
produc
ifni
rel
littl
tnf
deplet
cell
caus
signific
reduct
cell
ifnyproduc
cell
remain
like
cell
popul
present
infect
studi
typic
recent
studi
examin
cytokin
pattern
variou
lung
infect
lung
attempt
learn
determin
type
immun
respons
develop
airway
antigen
mice
use
determin
effect
ifni
influenza
clearanc
mice
develop
ctl
absens
class
mhc
residu
cell
capabl
mediat
clearanc
possibl
relat
develop
antibodi
subclass
sarawar
et
al
treatment
mice
antiifni
antibodi
delay
clearanc
least
day
wherea
antibodi
effect
howev
mice
surviv
eventu
clear
viru
notabl
neither
antibodi
ifni
alter
cytokin
profil
detect
freshli
isol
lung
lymphocyt
conclus
although
ifni
play
import
role
viral
clearanc
role
drive
cell
becom
h
l
cell
cell
develop
promin
compon
late
inflammatori
process
murin
influenza
infect
cell
express
known
gene
although
predomin
time
suggest
role
cell
recogn
heat
shock
protein
inflammatori
macrophag
decreas
number
howev
close
examin
data
fail
show
invers
relationship
number
cell
lung
macrophag
anoth
studi
cell
found
noncytolyt
express
mrna
ifni
gmcsf
tnfp
eichelberg
et
al
hypothesi
present
cell
capac
make
cytokin
provid
nonspecif
protect
secondari
infect
thu
although
cell
compon
host
respons
viral
lung
infect
role
remain
unknown
blue
ribbon
panel
vaccin
research
conven
anthoni
fauci
director
niaid
assess
longterm
goal
vaccin
research
recommend
immedi
prioriti
institut
among
panel
recommend
prioriti
develop
vaccin
respiratori
infect
children
improv
current
vaccin
pertussi
measl
addit
prioriti
develop
vaccin
reemerg
infecti
diseas
includ
influenza
inher
problem
antigen
drift
shift
jordan
report
public
divis
microbiolog
infecti
diseas
niaid
review
yearli
basi
progress
vaccin
research
report
respiratori
tract
infecti
diseas
vaccin
either
develop
improv
list
discuss
includ
bacteria
group
b
streptococci
h
influenza
type
b
nontyp
h
influenza
neisseria
meningitidi
pneumonia
b
pertussi
pseudomona
aeruginosa
tuberculosi
virus
rubeola
rubella
adenovirus
influenza
parainfluenza
virus
respiratori
syncyti
viru
mycoplasma
pneumonia
fungi
h
capsulatum
c
immiti
c
neoforman
thu
enorm
scientif
effort
direct
design
vaccin
protect
host
respiratori
pathogen
yet
report
also
highlight
gap
knowledg
normal
host
defens
mucos
surfac
immun
defens
attempt
enhanc
vaccin
best
method
immun
import
issu
vaccin
research
discuss
recent
public
lambert
includ
review
possibl
immun
tuberculosi
kaufmann
young
novel
approach
vaccin
inocul
polynucleotid
encod
antigen
directli
muscl
donnelli
et
al
import
gener
goal
vaccin
efficaci
easi
store
easi
give
free
side
effect
specif
goal
vaccin
respiratori
infect
immun
respons
gener
must
protect
corollari
immun
respons
microbi
challeng
caus
lung
patholog
immun
respons
must
quickli
avail
respiratori
tract
site
within
respiratori
tract
microorgan
like
seek
entranc
andor
produc
diseas
immun
memori
long
term
studi
type
protect
immun
respons
develop
natur
infect
man
induc
infect
experiment
anim
provid
import
clue
respons
enhanc
immun
product
approach
viral
infect
caus
intracellular
pathogen
howev
host
respons
prevent
second
infect
may
differ
immun
respons
bring
acut
infect
control
exampl
mani
viral
infect
although
cytotox
cell
may
bring
primari
infect
control
antibodi
may
prevent
reinfect
anoth
exampl
principl
although
cmi
control
cne
infect
mice
special
circumst
antibodi
cne
protect
mukheqje
et
al
isotyp
predomin
antibodi
prevent
infect
may
also
extrem
import
eg
upper
tract
infect
may
depend
iga
respons
alveolar
space
igg
may
effect
alreadi
discuss
import
consider
viral
vaccin
whether
subunit
vaccin
effect
live
attenu
organ
initi
desir
type
immun
respons
innov
strategi
gener
cmi
respons
nonviabl
antigen
inocul
regulatori
cytokin
time
antigen
deliveri
afonso
et
al
vaccin
could
even
consist
fusion
protein
antigen
cytokin
tao
levi
immun
respons
time
challeng
must
develop
correct
site
organ
infect
upper
respiratori
tract
local
iga
import
infect
initi
lower
respiratori
tract
may
suffici
protect
cell
antibodi
avail
circul
recruit
occur
immedi
follow
challeng
howev
signific
inflamm
requir
recruit
immun
cell
occur
clinic
manifest
infect
must
necessarili
develop
protect
respons
neutral
infect
feasibl
strategi
gener
iga
upper
respiratori
tract
aerosol
antigen
deliv
relev
antigen
surfac
nonpathogen
microorgan
streptococcu
gordonii
potenti
colon
nasopharynx
pozzi
et
al
immun
oral
vaccin
antigen
either
chemic
bound
cholera
toxin
bsubunit
mcghee
et
al
enclos
liposom
biodegrad
microspher
mestecki
eldrigd
encod
plasmid
carri
live
attenu
salmonella
spp
ckdena
clement
ampl
evid
document
iga
precursor
gener
gut
home
bronchial
mucosa
weiszcarrington
et
al
chen
et
al
et
al
although
convers
appear
occur
appreci
extent
mcdermott
bienenstock
joel
chanana
vancott
et
howev
cautionari
note
relationship
immun
enhanc
iga
respons
could
also
stimul
ige
respons
lead
allerg
respons
lung
oral
immun
protein
antigen
cholera
toxin
result
anaphylaxi
mice
follow
intraperiton
antigen
challeng
snider
et
al
import
issu
vaccin
whether
longterm
memori
possibl
base
data
deriv
immun
subunit
vaccin
kill
microorgan
seem
unlik
suffici
cell
memori
could
induc
longterm
cmi
protect
respiratori
tract
infect
howev
presenc
continu
antigen
would
occur
low
level
replic
attenu
virus
retain
intracellular
microorgan
iaposit
apc
memori
cell
persist
furthermor
follicular
dendrit
cell
present
balt
longterm
b
cell
memori
could
also
persist
due
retent
nonviabl
antigen
form
antigenantibodi
complex
cell
evid
longterm
b
cell
memori
occur
lung
dog
obtain
discuss
previous
howev
import
rememb
observ
made
anim
antigen
directli
instil
lung
therefor
obviou
extrapulmonari
immun
would
induc
retent
longterm
local
b
cell
memori
suggest
lung
immun
might
effect
primari
immun
respons
pulmonari
pathogen
boost
intranas
aerosol
antigen
deliveri
anim
model
human
lung
diseas
use
test
hypothes
well
control
condit
dissect
mechan
injuri
inflamm
repair
model
particularli
use
distinguish
direct
lung
toxic
injuri
result
immun
mechan
prove
lung
injuri
immun
mediat
requir
previou
exposur
appropri
agent
evid
specif
immun
respons
evid
injuri
involv
recogn
immunolog
mechan
earli
work
concentr
dissect
isol
aspect
immun
respons
ie
role
antibodi
antibodi
plu
complement
cell
emphas
vivo
analog
vitro
event
current
model
immunemedi
injuri
emphas
interrelationship
among
aspect
immun
respons
particular
import
cell
especi
cell
regul
type
immun
respons
better
appreci
earli
studi
immunemedi
lung
diseas
anim
perform
administ
differ
antigen
via
differ
rout
differ
adjuv
guinea
pig
richerson
immun
respons
vari
depend
type
antigen
method
immun
presum
predomin
respons
anim
immun
ovalbumin
ova
complet
freund
adjuv
cfa
develop
specif
complementactiv
antibodi
hemorrhag
pneumon
predomin
neutrophil
respons
aerosol
antigen
challeng
contrast
anim
immun
abanacetyltyrosin
cfa
exhibit
dth
without
demonstr
serum
antibodi
later
ova
aerosol
challeng
sensit
anim
produc
scatter
focal
area
alveol
thicken
increas
cellular
alveolar
septa
alveolar
fill
mononuclear
cell
work
brentjen
et
al
confirm
hemorrhag
natur
immun
complexmedi
lung
diseas
hemorrhag
neutrophil
pneumon
could
transfer
serum
suppress
administr
cobra
venom
factor
deplet
c
vivo
roska
et
al
richerson
colleagu
describ
result
aerosol
ova
exposur
rabbit
system
sensit
ova
cfa
acut
exposur
lead
transient
foci
acut
pulmonari
inflamm
richerson
et
al
wherea
chronic
exposur
caus
decreas
inflamm
richerson
et
al
cell
promin
acut
chronic
lesion
upadrashta
et
al
inhal
muramyl
dipeptid
could
substitut
system
immun
ova
freund
adjuv
pulmonari
inflammatori
respons
could
decreas
administr
cyclosporin
time
aerosol
challeng
kopp
et
al
implic
dth
etiolog
pulmonari
inflamm
rabbit
ova
model
diminut
patholog
respons
lung
despit
continu
challeng
could
produc
either
repeat
iv
aerosol
exposur
rabbit
ova
associ
decreas
antigenspecif
lymphocyt
prolifer
decreas
blood
bal
antibodi
respons
richerson
et
al
butler
et
al
similar
decreas
pulmonari
inflamm
observ
rabbit
guinea
pig
mice
subject
repeat
exposur
micropolyspora
faeni
agent
caus
farmer
lung
diseas
human
schuyler
et
al
schuyler
et
al
schuyler
et
al
thermoactinomycet
vulgari
caus
humidifi
lung
takizawa
et
al
decreas
pulmonari
inflamm
continu
challeng
attribut
desensit
defin
suppress
preexist
dth
administr
homolog
antigen
howev
desensit
clearli
present
model
lung
diseas
lymphocyt
prolifer
antibodi
respons
depress
sinc
desensit
system
achiev
administr
antigen
unusu
rout
oral
weigl
rather
surpris
immunolog
desensit
evid
model
repetit
pulmonari
instil
antigen
two
possibl
mechan
increas
degrad
inhal
antigen
increas
suppress
lymphocyt
prolifer
present
model
schuyler
schmitt
kopp
et
al
addit
possibl
includ
decreas
exposur
lung
antigen
due
chang
clearanc
mechan
chang
lymphocyt
subtyp
investig
b
immun
complexmedi
lung
injuri
ward
colleagu
extend
studi
immun
complexmedi
lung
injuri
use
intratrach
instil
antibodi
bovin
serum
albumin
bsa
follow
iv
administr
bsa
lung
injuri
measur
use
morpholog
leakag
label
intravascular
protein
red
blood
cell
lung
quantit
neutrophil
enzym
myeloperoxidas
lung
johnson
ward
mark
differ
shown
respons
instil
igg
versu
iga
immun
complex
igg
immun
complexmedi
damag
character
neutrophil
infiltr
lung
evid
increas
pulmonari
vascular
permeabl
neutrophil
depend
warren
et
al
requir
illp
plateletactiv
factor
warren
like
produc
tnfastimul
macrophag
warren
et
express
mulligan
et
c
function
receptor
mulligan
et
al
cdlla
cdllb
express
also
involv
mulligan
et
al
upregul
pulmonari
venul
capillari
endothelium
perhap
mediat
rat
analog
mulligan
et
al
mulligan
et
al
upregul
express
modul
tnfa
mulligan
et
al
contrast
iga
immun
complex
lung
injuri
character
accumul
mononuclear
cell
warren
et
al
perhap
mediat
monocyt
chemoattract
protein
jone
et
al
injuri
neutrophil
tnfa
independ
modul
increas
express
mulligan
et
al
tnfa
secret
despit
tnfainduc
increas
express
igamedi
injuri
similar
igg
immun
complex
injuri
depend
dissimilar
depend
c
l
l
b
c
l
l
express
mulligan
et
az
iga
immun
complex
lung
injuri
appar
mediat
nitric
oxid
deriv
protect
pulmonari
respons
igg
immun
complex
wherea
protect
iga
immun
complexmedi
injuri
mulligan
et
al
c
asthma
model
multipl
anim
eg
primat
sheep
guinea
pig
dog
rabbit
rat
model
asthma
use
explor
pathophysiolog
aspect
asthma
wegner
et
al
abraham
w
murray
et
al
lukac
et
al
yamaya
et
al
du
et
al
waserman
et
al
coyl
et
al
method
test
effect
variou
therapeut
agent
although
resembl
human
asthma
substanti
differ
especi
regard
physiolog
respons
airway
challeng
method
induc
immun
hyperreact
typic
protocol
use
intraperiton
administr
antigen
aluminum
hydroxid
andor
bordetella
adjuv
guinea
pig
immun
intraperiton
ova
aluminum
hydroxid
adjuv
often
addit
pertussi
handley
et
al
mauser
et
al
induc
form
ige
igg
antibodi
exhibit
airway
blood
eosinophilia
display
earli
latephas
bronchoconstrict
cerasoli
et
al
reexpos
ova
anim
also
demonstr
increas
bronchial
reactiv
histamin
acetylcholin
administ
iv
use
method
sensit
guinea
pig
exhibit
strain
differ
blood
eosoniphilia
bronchial
hyperreact
winthereik
et
al
increas
respons
acetylcholin
antigen
challeng
latephas
bronchoconstrict
correl
bal
neutrophilia
asano
et
al
method
immun
differ
occur
human
pulmonari
physiolog
respons
guinea
pig
dissimilar
human
asthma
guinea
pig
expos
variou
parasit
antigen
also
exhibit
airway
hyperreact
yamaya
et
al
nonhuman
primat
expos
ascari
suum
antigen
via
airway
exhibit
immedi
skin
test
reactiv
either
earli
earli
late
increas
airway
resist
patterson
harri
dual
respons
associ
bal
eosinophil
greater
increas
bal
neutrophil
gundel
et
al
hirshman
colleagu
found
ascarissensit
basenji
greyhound
dog
exhibit
number
chang
similar
human
asthma
includ
increas
specif
nonspecif
airway
reactiv
increas
number
bal
mast
cell
hirshman
et
al
hirshman
et
al
spontan
induc
histamin
releas
bal
mast
cell
increas
compar
control
anim
hirshman
et
al
tracheal
muscl
anim
exhibit
impair
usual
increas
cyclic
amp
respons
isoproterenol
emala
et
al
coincid
measur
collater
airway
resist
high
resolut
ct
scan
detect
airway
narrow
herold
et
al
corddri
et
al
chronic
treatment
methylprednisolon
decreas
nonspecif
airway
reactiv
bal
eosinophil
number
darowski
et
al
other
induc
asthmalik
syndrom
increas
bronchial
reactiv
reagin
antibodi
dog
immun
intraperiton
puppi
haptencarri
complex
aluminum
hydroxid
adjuv
kepon
et
al
later
work
extend
model
use
ragwe
antigen
baldwin
becker
becker
et
al
immun
dog
exhibit
immediateand
latephas
skin
test
reactiv
becker
et
al
increas
antigenspecif
nonspecif
bronchial
reactiv
increas
bal
mast
cell
eosinophil
histamin
becker
et
al
cell
appear
import
anim
model
asthma
frew
colleagu
demonstr
substanti
influx
presum
cell
bronchial
wall
mucosa
adventitia
aerosol
antigen
challeng
guinea
pig
undergo
latephas
bronchoconstrict
frew
et
al
use
picryl
chlorid
epicutan
sensit
mice
challeng
intranas
hapten
exhibit
peribronchiolar
cellular
infiltr
increas
pulmonari
resist
vivo
garssen
et
al
hypersensit
carbacol
present
trachea
anim
could
transfer
cell
sensit
anim
phenomenon
could
produc
athym
mice
garssen
et
al
cyclosporin
administr
prevent
develop
late
asthmat
respons
bronchial
hyperrespons
antigen
challeng
fukuda
et
al
class
mhcdefici
mice
lack
matur
cell
could
express
peribronchiolar
inflamm
bal
lymphocytosi
eosinophilia
expos
ova
brussel
et
al
exposur
mice
certain
parasit
eg
schistosom
also
caus
appear
intrapulmonari
bal
eosinophilia
via
ilcdepend
mechan
lukac
et
al
perhap
alter
balanc
versu
h
l
cell
number
lung
antibodi
ablat
eosinophil
airway
respons
ova
exposur
sensit
guinea
pig
even
block
ovainduc
increas
sensit
substanc
p
chand
et
al
mauser
et
al
eosinophil
infiltr
trachea
sensit
mice
aerosol
antigen
challeng
depend
cell
nakajima
et
al
block
inocul
ifni
iwamoto
et
al
gelfand
colleagu
develop
model
asthma
balbc
mice
typic
high
ige
respond
induc
repetit
inhal
ova
anim
exhibit
increas
specif
ige
product
increas
sensit
iv
methacholin
evid
sensit
cell
laln
spleen
capabl
produc
specif
ige
iggl
isol
trachea
sensit
anim
hyperrespons
electr
field
stimul
specif
ige
antibodi
increas
airway
reactiv
could
induc
naiv
recipi
transfer
sensit
cell
laln
spleen
cell
follow
singl
aerosol
ova
exposur
lowig
respond
sjl
l
mice
fail
develop
either
ige
antibodi
increas
bronchial
respons
although
develop
specif
igg
antibodi
larsen
wicht
local
airway
challeng
well
system
sensit
requir
develop
airway
hyperreact
suggest
local
factor
addit
system
sensit
requir
bronchial
hyperreact
model
ifni
administr
ova
sensit
decreas
specif
ige
product
ablat
increas
airway
reactiv
effect
ifni
depend
rout
administr
system
administr
decreas
serumspecif
ige
lalnspecif
ige
product
perhap
importantli
ovainduc
increas
airway
reactiv
ablat
airway
system
ifni
administr
lack
et
al
result
compat
ifnyinduc
shift
predomin
h
l
cell
respons
also
gave
evid
compartment
system
airway
immun
respons
thu
airway
hyperrespons
correl
laln
system
sensit
cellmedi
hypersensit
cellmedi
inflamm
lung
result
pulmonari
fibrosi
hypersensit
pneumon
hp
exposur
mice
hapten
instil
lung
caus
system
sensit
measur
ear
swell
reexposur
sensit
hapten
steinstreilein
furthermor
follow
epicutan
sensit
lipophil
trinitrophenylchlorobenzen
intratrach
challeng
watersolubl
hapten
trinitrophenyl
pulmonari
fibrosi
develop
intratrach
rechalleng
unrel
hapten
dinitrophenol
produc
pulmonari
fibrosi
steinstreilein
et
al
model
similar
previou
model
contact
sensit
use
skin
sensit
challeng
consist
cellmedi
dth
process
polack
differ
inbr
mous
strain
anim
exhibit
coincid
skin
reactiv
abil
develop
pulmonari
fibrosi
kimura
et
al
induct
toler
inject
haptencoupl
splenocyt
sensit
depress
skin
pulmonari
respons
follow
tracheal
challeng
kimura
et
al
inflammatori
fibrot
respons
intratrach
hapten
challeng
transfer
immun
lymphocyt
immun
serum
uivo
administr
antibodi
sensit
mice
prevent
amelior
inflammatori
fibrot
respons
tracheal
challeng
develop
pulmonari
fibrosi
associ
bal
activ
lymphotoxin
mrna
bal
nonadher
cell
garcia
et
al
increas
ratio
procollagen
type
iii
mrna
fibroblast
immun
challeng
anim
develop
indic
qualit
well
quantit
collagen
differ
occur
steinstreilein
et
al
bleomycin
mixtur
glycoprotein
streptomyc
uerticullu
use
clinic
antineoplast
properti
predict
caus
pulmonari
fibrosi
hamster
model
intratrach
administr
singl
dose
bleomycin
experiment
anim
caus
pulmonari
fibrosi
resembl
clinic
pulmonari
interstiti
fibrosi
albeit
differ
pattern
fibrosi
usual
interstiti
fibrosi
snider
et
al
evid
accumul
cytokin
import
mediat
anim
fibrosi
model
increas
tgfp
khalil
et
al
tnfa
piguet
et
al
jordana
et
al
brieland
et
al
macrophagederiv
growth
factor
fibroblast
denholm
phan
detect
lung
pulmonari
cell
deriv
anim
expos
bleomycin
administr
antitnfa
prevent
fibrosi
piguet
et
al
although
mani
cytokin
studi
concentr
role
recent
report
indic
pulmonari
endotheli
cell
constitut
produc
increas
exposur
bleomycin
karmiol
et
al
produc
fibroblast
rolf
et
al
tgfp
produc
pulmonari
arteri
endotheli
cell
phan
et
al
lung
fibroblast
breen
et
al
therefor
sourc
cytokin
bleomycininduc
pulmonari
fibrosi
could
includ
nonmacrophag
pulmonari
cell
well
macrophag
despit
evid
toxic
bleomycininduc
macrophagederiv
cytokin
sever
studi
suggest
cell
may
also
import
differ
strain
mice
respond
differ
intratrach
bleomycin
schrier
et
al
pulmonari
fibrosi
occur
athym
nude
mice
schrier
et
al
deplet
cell
prevent
fibrosi
jordana
et
al
cormier
colleagu
describ
model
hp
associ
alveol
fibrosi
caus
repeat
pulmonari
instil
fueni
associ
increas
bal
illa
tnfa
deni
et
al
cyclosporin
administr
block
pulmonari
fibrosi
alveol
bal
illa
tnfa
deni
et
ul
suggest
role
cell
produc
fibrosi
pulmonari
fibrosi
also
prevent
antitnfa
antibodi
deni
et
al
evid
also
found
role
amsecret
tgfp
promot
fibrosi
deni
ghadirian
secret
tnfa
probabl
origin
pulmonari
macrophag
foster
gmcsf
secret
lymphocyt
expos
faeni
contrast
adopt
transfer
model
hp
describ
uivo
deplet
cell
substanti
affect
pulmonari
histolog
respons
faeni
might
relat
repetit
challeng
agent
adjuv
effect
bice
et
al
inflamm
model
macrophag
rather
lymphocyt
driven
pulmonari
fibrosi
induc
repeat
challeng
fueni
increas
bal
inflammatori
cell
reduc
administr
la
implic
integrin
process
lead
fibrosi
model
deni
bisson
lymphocyt
implic
model
hp
cyclosporin
administr
amelior
pulmonari
lesion
anim
subject
airway
challeng
uulgari
takizawa
et
al
nude
mice
exhibit
pulmonari
lesion
hp
exposur
abl
produc
lesion
cellsuffici
litterm
abil
express
pulmonari
lesion
could
transfer
cell
sensit
mice
takizawa
et
al
schuyler
colleagu
develop
adopt
transfer
murin
model
experiment
hp
use
faeni
cell
adopt
transfer
obtain
spleen
peripher
lymph
node
laln
periton
exud
immun
anim
cell
restimul
cultur
relev
antigen
could
transfer
naiv
recipi
suscept
increas
lung
inflamm
follow
intratrach
rechalleng
antigen
schuyler
et
al
ifnr
present
substanti
quantiti
cultur
fei
et
al
cell
requir
begin
cultur
gener
effect
cell
adopt
transfer
schuyler
et
al
transfer
cell
mixtur
naiv
memori
cell
defin
lselectin
express
schuyler
et
al
schuyler
et
al
success
transfer
also
depend
presenc
cell
recipi
schuyler
et
al
suggest
necess
import
interact
host
recipi
cell
despit
differ
method
develop
model
lung
allograft
gvhd
immunolog
respons
lung
show
similar
histolog
pattern
sever
studi
document
similar
atkinson
et
al
emeson
et
al
piguet
et
al
randhawa
yousen
steinstreilein
et
al
yousem
et
al
histoincompat
allograft
lung
recogn
foreign
recipi
therefor
subject
reject
randhawa
yousem
gvhd
donor
immunocompet
allogen
cell
recogn
recipi
foreign
farrara
deeg
disord
pulmonari
manifest
lung
allograft
reject
gvhd
may
separ
acut
chronic
chang
acut
lung
allograft
reject
initi
patholog
lesion
perivascular
mononuclear
cell
infiltr
term
minim
reject
grade
yousem
eta
sever
perivascular
mononuclear
cell
infiltr
consist
activ
lymphocyt
plasma
cell
macrophag
call
mild
acut
reject
grade
yousem
et
al
instanc
rare
eosinophil
present
yousem
et
al
vascular
chang
may
includ
degener
endothelium
endotheli
yousem
et
al
randhawa
yousem
lymphocyt
infiltr
bronchiol
may
present
yousem
et
al
grade
acut
lung
cancer
allograft
reject
also
known
moder
acut
reject
infiltr
progress
becom
appar
around
pulmonari
vein
arteriol
peribron
gvhd
lung
patholog
comparison
chiolar
area
yousem
et
al
grade
sever
acut
reject
mononuclear
cell
infiltr
extend
air
space
involv
vessel
bronchiol
necrot
vascul
parenchym
necrosi
may
also
visibl
randhawa
yousem
contrast
acut
lung
allograft
reject
pulmonari
patholog
acut
gvhd
assign
histolog
grade
beschorn
et
al
first
describ
acut
chang
gvhd
lung
recipi
bone
marrow
transplant
patient
patholog
limit
lymphocyt
bronchiti
beschorn
et
al
recent
atkinson
et
al
report
acut
pulmonari
syndrom
bone
marrow
transplant
resembl
acut
gvhd
lung
lesion
includ
lymphocyt
peribronchi
infiltr
bronchial
epitheli
degener
lymphocyt
perivascular
infiltr
atkinson
et
al
rel
histolog
acut
lung
allograft
reject
pulmonari
chang
observ
acut
gvhd
lung
analog
grade
reject
respons
anim
model
investig
report
acut
gvhdlike
chang
lung
piguet
et
al
steinstreilein
et
al
wilk
et
al
studi
histolog
lesion
includ
alveol
lymphocyt
bronchiti
vascul
histolog
chang
acut
gvhd
analog
grade
sever
acut
reject
lung
allograft
allograft
reject
gvhd
lung
patholog
lesion
airway
began
level
bronchiol
extend
alveolar
space
chronic
stage
lung
allograft
reject
gvhd
associ
develop
bronchiol
obliteran
bo
farrara
deeg
rhandhawa
yousem
yousem
et
al
bronchiol
obliteran
lesion
specif
allograft
reject
gvhd
fact
associ
varieti
condit
epler
includ
toxic
fume
inhal
rheumatoid
arthriti
penicillamin
use
postinfecti
etiolog
well
idiopath
caus
histolog
bo
show
granul
tissu
plug
within
lumen
small
airway
epitheli
cell
damag
mononuclear
cell
infiltr
time
complet
obstruct
airway
epler
randhawa
yousem
bronchiol
obliteran
observ
chronic
lung
allograft
reject
gvhd
involv
membran
respiratori
bronchiol
possibl
involv
proxim
airway
randhawa
yousem
contrast
patholog
observ
acut
diseas
lymphocyt
perivascular
infiltr
present
bo
case
associ
chronic
lung
allograft
reject
randhawa
yousem
degre
vascular
involv
bo
associ
chronic
gvhd
unknown
like
less
acut
gvhd
canin
rat
model
util
studi
lung
transplant
immunopathogenesi
reject
benfield
prop
et
al
b
howev
avail
immunolog
reagent
allow
rat
model
develop
marck
prop
wildevuur
extens
studi
marck
et
al
orthotop
transplant
brown
norway
rat
lung
allograft
rt
lewi
rt
rat
result
histolog
immunolog
chang
analog
human
lung
transplant
marck
et
al
prop
et
al
b
reject
process
occur
four
phase
prop
et
al
b
latent
phase
occur
immedi
transplant
immunolog
activ
describ
graft
day
transplant
vascular
phase
character
infiltr
balt
perivascular
tissu
lymphocyt
day
transplant
alveolar
phase
mononuclear
cell
infiltr
alveolar
wall
day
transplant
destruct
phase
character
intraalveolar
edema
destruct
airway
vessel
infiltr
mononuclear
cell
day
posttransplant
significantli
four
phase
resembl
somewhat
four
grade
associ
acut
reject
human
yousem
et
al
studi
describ
histolog
chang
associ
acut
reject
two
report
current
exist
literatur
describ
anim
model
chronic
reject
known
bo
hertz
et
al
uyama
et
al
util
previous
describ
rat
lung
allograft
model
rat
made
toler
allograft
cyclosporin
develop
typic
chang
bo
around
month
transplant
airway
lesion
associ
upregul
class
mhc
express
epithelium
larg
airway
aggreg
dc
submucosa
ulcer
epithelium
uyama
et
al
murin
model
util
hetertop
transplant
airway
characterist
lesion
bo
develop
allograft
day
hertz
et
al
signific
differ
rat
model
clinic
transplant
one
two
dose
immunosuppress
drug
cyclosporin
result
indefinit
accept
donor
rat
lung
uyama
et
al
human
lung
allograft
recipi
usual
requir
lifelong
therapi
prevent
reject
trulock
howev
without
cyclosporin
rat
lung
allograft
undergo
rapid
reject
process
usual
result
destruct
allograft
day
posttransplant
prop
et
al
b
although
lung
transplant
becom
increasingli
util
modal
treatment
mani
endstag
lung
diseas
trulock
lung
allograft
anim
model
human
prone
reject
solid
organ
prop
et
al
b
trulock
presenc
mani
immunocompet
cell
present
donor
lung
stimul
reject
respons
may
explan
prop
et
al
b
trulock
notabl
despit
larg
number
lymphocyt
present
lung
thu
carri
recipi
clinic
syndrom
system
gvhd
report
human
lung
allograft
individu
howev
gvhd
lung
transplant
report
anim
model
recipi
render
sever
immunoincompet
total
bodi
irradi
prop
et
al
acut
lung
allograft
reject
believ
initi
donor
lung
apc
ie
dc
perhap
macrophag
interact
recipi
lymphocyt
winter
et
al
although
direct
evid
accessori
cell
mediat
allograft
reject
sever
studi
suggest
role
reject
respons
acut
reject
episod
commonli
occur
time
abund
donor
dc
lung
macrophag
ie
first
week
transplant
diminish
cell
replac
recipi
paradi
et
al
uyama
et
al
util
murin
model
renal
transplant
dc
deplet
lechler
demonstr
replet
dc
result
reject
allograft
lechler
batchelor
similarli
block
antibodi
dc
result
prolong
surviv
murin
pancreat
islet
allograft
faustman
et
al
discuss
previous
dc
exist
within
epithelium
subepitheli
area
bronchibronchiol
area
involv
acut
chronic
reject
addit
ifni
cytokin
crucial
reject
process
oconnel
et
al
shown
upregul
number
dc
interstitium
surround
pulmonari
capillari
within
alveolar
interstitium
bronchial
epithelium
final
dc
accumul
area
bo
cours
chronic
allograft
reject
uyama
et
al
collect
studi
suggest
central
role
dc
pathogenesi
lung
allograft
reject
lung
macrophag
although
suppress
mani
immun
cell
function
may
also
involv
initi
reject
respons
lung
accessori
celllymphocyt
interact
occur
cytokin
intercellular
signal
result
upregul
cellular
humor
immun
wilk
weissler
cellular
immun
crucial
lung
allograft
reject
prop
et
al
b
may
result
differenti
stimul
h
l
versu
cell
h
l
lymphocyt
play
signific
role
pathogenesi
solid
organ
allograft
reject
jordan
et
al
oconnel
et
al
exampl
murin
exampl
pancreat
islet
reject
allograft
infiltr
lymphocyt
preferenti
express
mrna
ifni
oconnel
et
al
similarli
rat
lung
allograft
ifni
mrna
express
reject
episod
jordan
et
al
clinic
import
h
l
lymphocyt
allograft
reject
exemplifi
fact
primari
immunosuppress
agent
use
recipi
human
lung
allograft
cyclosporin
preferenti
inhibit
ifni
product
lymphocyt
cockfield
et
al
contrast
lymphocyt
activ
ie
product
downregul
h
l
activ
strongli
associ
prevent
allograft
reject
gorczynski
wojcik
allogen
parenchym
lung
dc
potent
induc
ifni
lymphocyt
wilk
weissler
collect
data
suggest
allograft
reject
part
mediat
lung
macrophag
dc
stimul
h
l
lymphocyt
cytokin
h
l
lymphocyt
result
specif
immunoglobulin
product
kitani
strober
therefor
upregul
h
l
lymphocyt
activ
observ
allograft
reject
might
respons
enhanc
local
immunoglobulin
product
observ
reject
process
wilk
et
al
ifni
h
l
cytokin
stimul
murin
b
lymphocyt
kitani
strober
furthermor
ifni
product
induc
human
lung
macrophag
select
stimul
product
allogen
peripher
blood
mononuclear
cell
wilk
weissler
recipi
lung
allograft
undergo
reject
wilk
demonstr
local
product
select
upregul
thu
serv
marker
reject
respons
wilk
et
al
studi
demonstr
role
alloantibodi
mediat
process
lung
allograft
reject
coronari
atherosclerosi
secondari
murin
cardiac
allograft
reject
part
mediat
antibodi
direct
donor
coronari
epithelium
russel
et
az
similarli
iggl
produc
local
human
lung
allograft
reject
preferenti
bound
perivascular
peribronchi
extracellular
connect
tissu
matric
anatom
locat
involv
reject
process
wilk
manuscript
prepar
taken
togeth
studi
suggest
role
thldepend
humor
respons
pathogenesi
lung
allograft
reject
lung
accessori
cellt
lymphocyt
interact
initi
organ
reject
winter
et
al
product
proinflammatori
cytokin
tnfa
identifi
mediat
ofth
reject
process
saito
et
al
evid
tnfa
involv
reject
demonstr
demeest
report
tnfa
mrna
protein
upregul
lung
tissu
acut
reject
rat
lung
allograft
significantli
antitnfa
antibodi
reduc
vascul
hemorrhag
lesion
reject
lung
allograft
saito
et
al
similarli
upregul
lung
reject
postul
clinic
import
follow
activ
reject
process
c
model
graft
versu
host
diseas
lung
gvhd
system
process
rel
describ
pulmonari
involv
anim
model
gvhd
piguet
et
al
steinstreilein
et
al
steinstreilein
et
al
util
murin
model
report
gvhd
reaction
lung
studi
suspens
parent
mha
lymph
node
cell
instil
trachea
hybrid
mha
x
cb
recipi
hamster
histolog
observ
recipi
lung
show
mononuclear
cell
infiltr
interstitium
alveolar
peribronchiolar
perivascular
area
anim
develop
thymic
atrophi
splenomegali
suggest
system
compon
diseas
process
steinstreilein
et
al
interestingli
cell
given
iv
intracutan
anim
develop
system
gvhd
without
distinct
pulmonari
patholog
steinstreilein
et
al
piguet
also
studi
pulmonari
diseas
associ
gvhd
studi
irradi
hybrid
cba
x
mice
inject
either
parent
lymphocytedeplet
bone
marrow
cell
parent
bone
marrow
cell
togeth
suspens
lymph
node
cell
sourc
lymphocyt
addit
induct
system
gvhd
histolog
lung
similar
report
steinstreilein
addit
investig
demonstr
central
role
lymphocyt
lung
patholog
gvhd
inject
lymphocytedeplet
bone
marrow
cell
induc
pulmonari
patholog
piguet
et
al
wilk
et
al
recent
report
allogen
bal
accessori
cell
go
macrophag
instil
intratrach
lung
normal
balbc
mice
weekli
week
induc
lymphocyt
alveol
bronchiti
vascul
analog
gvhd
lung
acut
lung
allograft
reject
unlik
anim
model
gvhd
piguet
et
al
steinstreilein
et
al
recipi
mice
evid
system
diseas
addit
allogen
challeng
perform
pulmonari
lesion
eventu
heal
previous
state
clinic
manifest
chronic
gvhd
lung
associ
develop
bo
farrara
deeg
randhawa
yousem
yousem
et
al
contrast
anim
model
chronic
gvhd
report
associ
type
pulmonari
diseas
immunopathogenesi
anim
model
gvhd
well
describ
antin
farrara
piguet
et
al
similar
acut
lung
allograft
reject
acut
gvhd
associ
product
sever
proinflammatori
cytokin
includ
tnfa
antin
farrara
piguet
et
al
fact
receptor
antagonist
shown
significantli
inhibit
gvhd
rel
lung
antitnfa
antibodi
partial
prevent
pulmonari
patholog
gvhd
piguet
et
al
proinflammatori
cytokin
involv
pathogenesi
gvhd
lymphocyt
initi
process
antin
farrara
h
l
lymphocyt
crucial
acut
gvhd
amurin
model
gvhd
ifni
preferenti
produc
cours
acut
gvhd
allen
et
al
similar
find
report
investig
antin
farrara
therefor
immun
respons
alloantigen
lung
allograft
reject
gvhd
seem
associ
upregul
h
l
lymphocyt
activ
role
humor
immun
gvhd
well
defin
howev
wilk
et
al
report
allogen
bal
cell
instil
murin
lung
result
predomin
local
product
addit
shown
deposit
perivascular
peribronchiolar
extracellular
connect
tissu
anatom
locat
involv
lung
allograft
reject
gvhd
lung
data
suggest
local
produc
immunoglobulin
recogn
compon
extracellular
connect
tissu
matrix
may
involv
pathogenesi
gvhd
lung
evid
emerg
suggest
principl
immun
deriv
studi
cell
bodi
site
contradict
lung
associ
lymphoid
tissu
clear
howev
environ
dictat
type
cell
relationship
one
anoth
perturb
event
set
motion
either
develop
activ
immun
respons
toler
investig
mechan
develop
lung
immun
increas
understand
human
diseas
develop
continu
suggest
new
way
manipul
pulmonari
immun
respons
demonstr
lung
cell
regul
nonspecif
inflamm
immun
express
adhes
molecul
secret
cytokin
offer
hope
way
design
effect
vaccin
enhanc
microbi
clearanc
immunosuppress
host
suppress
manifest
immunolog
mediat
lung
diseas
import
lung
diseas
target
intens
research
effort
immedi
futur
tuberculosi
asthma
fibrot
lung
diseas
perhap
even
common
cold
might
conquer
consid
pace
current
research
lung
immun
may
ambiti
predict
diseas
may
conquer
next
decad
